--06-30 2026 Q1 0001001250 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure el:numberOfEmployee el:agency el:classAction el:complaint el:case el:segment el:product_category 0001001250 2025-07-01 2025-09-30 0001001250 us-gaap:CommonClassAMember 2025-10-23 0001001250 us-gaap:CommonClassBMember 2025-10-23 0001001250 2024-07-01 2024-09-30 0001001250 2025-09-30 0001001250 2025-06-30 0001001250 us-gaap:CommonClassAMember 2025-09-30 0001001250 us-gaap:CommonClassAMember 2025-06-30 0001001250 us-gaap:CommonClassBMember 2025-06-30 0001001250 us-gaap:CommonClassBMember 2025-09-30 0001001250 2024-06-30 0001001250 2024-09-30 0001001250 us-gaap:LandAndLandImprovementsMember 2025-09-30 0001001250 us-gaap:LandAndLandImprovementsMember 2025-06-30 0001001250 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2025-09-30 0001001250 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2025-06-30 0001001250 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2025-09-30 0001001250 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2025-06-30 0001001250 us-gaap:BuildingAndBuildingImprovementsMember 2025-09-30 0001001250 us-gaap:BuildingAndBuildingImprovementsMember 2025-06-30 0001001250 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2025-06-30 0001001250 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2025-09-30 0001001250 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2025-09-30 0001001250 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2025-06-30 0001001250 us-gaap:MachineryAndEquipmentMember 2025-09-30 0001001250 us-gaap:MachineryAndEquipmentMember 2025-06-30 0001001250 srt:MinimumMember el:ComputerHardwareAndSoftwareMember 2025-09-30 0001001250 srt:MinimumMember el:ComputerHardwareAndSoftwareMember 2025-06-30 0001001250 srt:MaximumMember el:ComputerHardwareAndSoftwareMember 2025-09-30 0001001250 srt:MaximumMember el:ComputerHardwareAndSoftwareMember 2025-06-30 0001001250 el:ComputerHardwareAndSoftwareMember 2025-09-30 0001001250 el:ComputerHardwareAndSoftwareMember 2025-06-30 0001001250 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2025-09-30 0001001250 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2025-06-30 0001001250 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2025-06-30 0001001250 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2025-09-30 0001001250 us-gaap:FurnitureAndFixturesMember 2025-09-30 0001001250 us-gaap:FurnitureAndFixturesMember 2025-06-30 0001001250 us-gaap:LeaseholdImprovementsMember 2025-09-30 0001001250 us-gaap:LeaseholdImprovementsMember 2025-06-30 0001001250 us-gaap:ConstructionInProgressMember 2025-09-30 0001001250 us-gaap:ConstructionInProgressMember 2025-06-30 0001001250 srt:MinimumMember 2025-09-30 0001001250 srt:MaximumMember 2025-09-30 0001001250 el:SkinCareMember 2025-06-30 0001001250 el:MakeupMember 2025-06-30 0001001250 el:FragranceMember 2025-06-30 0001001250 el:HairCareMember 2025-06-30 0001001250 el:SkinCareMember 2025-07-01 2025-09-30 0001001250 el:MakeupMember 2025-07-01 2025-09-30 0001001250 el:FragranceMember 2025-07-01 2025-09-30 0001001250 el:HairCareMember 2025-07-01 2025-09-30 0001001250 el:SkinCareMember 2025-09-30 0001001250 el:MakeupMember 2025-09-30 0001001250 el:FragranceMember 2025-09-30 0001001250 el:HairCareMember 2025-09-30 0001001250 el:CustomerListsAndOtherMember 2025-09-30 0001001250 el:CustomerListsAndOtherMember 2025-06-30 0001001250 us-gaap:TrademarksMember 2025-09-30 0001001250 us-gaap:TrademarksMember 2025-06-30 0001001250 el:RestructuringProgramMember 2024-02-05 2024-02-05 0001001250 srt:MinimumMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 srt:MaximumMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 srt:MinimumMember el:RestructuringProgramMember 2025-09-30 0001001250 srt:MaximumMember el:RestructuringProgramMember 2025-09-30 0001001250 us-gaap:SalesReturnsAndAllowancesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:CostOfSalesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:OtherOperatingIncomeExpenseMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:SalesReturnsAndAllowancesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:CostOfSalesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:OtherOperatingIncomeExpenseMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:SalesReturnsAndAllowancesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:CostOfSalesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:OtherOperatingIncomeExpenseMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:SalesReturnsAndAllowancesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 us-gaap:CostOfSalesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 us-gaap:OtherOperatingIncomeExpenseMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 us-gaap:SalesReturnsAndAllowancesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 us-gaap:CostOfSalesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 us-gaap:OtherOperatingIncomeExpenseMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 us-gaap:EmployeeSeveranceMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 el:ImpairmentInValueOfAssetsMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:ContractTerminationMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:OtherRestructuringMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:EmployeeSeveranceMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 el:ImpairmentInValueOfAssetsMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:ContractTerminationMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:OtherRestructuringMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:EmployeeSeveranceMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 el:ImpairmentInValueOfAssetsMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:ContractTerminationMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:OtherRestructuringMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:EmployeeSeveranceMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 el:ImpairmentInValueOfAssetsMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 us-gaap:ContractTerminationMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 us-gaap:OtherRestructuringMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-26 0001001250 us-gaap:EmployeeSeveranceMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 el:ImpairmentInValueOfAssetsMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 us-gaap:ContractTerminationMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 us-gaap:OtherRestructuringMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember us-gaap:SubsequentEventMember 2024-02-05 2025-10-26 0001001250 us-gaap:EmployeeSeveranceMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 el:ImpairmentInValueOfAssetsMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:ContractTerminationMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:OtherRestructuringMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:RestructuringChargesMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-06-30 0001001250 us-gaap:EmployeeSeveranceMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 el:ImpairmentInValueOfAssetsMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:ContractTerminationMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:OtherRestructuringMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:RestructuringChargesMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:EmployeeSeveranceMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 el:ImpairmentInValueOfAssetsMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:ContractTerminationMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:OtherRestructuringMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:RestructuringChargesMember us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2024-02-05 2025-09-30 0001001250 us-gaap:EmployeeSeveranceMember el:RestructuringProgramMember 2025-06-30 0001001250 el:ImpairmentInValueOfAssetsMember el:RestructuringProgramMember 2025-06-30 0001001250 us-gaap:ContractTerminationMember el:RestructuringProgramMember 2025-06-30 0001001250 us-gaap:OtherRestructuringMember el:RestructuringProgramMember 2025-06-30 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-06-30 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-07-01 2025-09-30 0001001250 us-gaap:EmployeeSeveranceMember el:RestructuringProgramMember 2025-09-30 0001001250 el:ImpairmentInValueOfAssetsMember el:RestructuringProgramMember 2025-09-30 0001001250 us-gaap:ContractTerminationMember el:RestructuringProgramMember 2025-09-30 0001001250 us-gaap:OtherRestructuringMember el:RestructuringProgramMember 2025-09-30 0001001250 us-gaap:RestructuringChargesMember el:RestructuringProgramMember 2025-09-30 0001001250 srt:ScenarioForecastMember el:RestructuringProgramMember 2025-10-01 2026-06-30 0001001250 srt:ScenarioForecastMember el:RestructuringProgramMember 2026-07-01 2027-06-30 0001001250 srt:ScenarioForecastMember el:RestructuringProgramMember 2027-07-01 2028-06-30 0001001250 us-gaap:NondesignatedMember 2025-09-30 0001001250 us-gaap:InterestRateSwapMember el:TwoPointSixZeroZeroPercentSeniorNotesDueAprilTwentyThirtyMember us-gaap:FairValueHedgingMember 2025-09-30 0001001250 us-gaap:InterestRateSwapMember el:OnePointNineFiveZeroPercentSeniorNotesDueMarchTwentyThirtyOneMember us-gaap:FairValueHedgingMember 2025-09-30 0001001250 us-gaap:InterestRateSwapMember el:FivePointZeroZeroZeroPercentSeniorNoteDueFebruaryTwentyThirtyFourMember us-gaap:FairValueHedgingMember 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:FairValueHedgingMember 2025-09-30 0001001250 us-gaap:CurrencySwapMember 2025-07-01 2025-09-30 0001001250 us-gaap:CurrencySwapMember 2025-09-30 0001001250 us-gaap:CurrencySwapMember 2025-06-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2025-09-30 0001001250 us-gaap:CashFlowHedgingMember 2025-09-30 0001001250 us-gaap:CashFlowHedgingMember 2025-06-30 0001001250 el:ForeignExchangeForwardAndCrossCurrencySwapMember us-gaap:NetInvestmentHedgingMember 2025-09-30 0001001250 us-gaap:DerivativeMember 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember el:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember el:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:CurrencySwapMember el:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:CurrencySwapMember el:PrepaidExpensesAndOtherCurrentAssetsAndOtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:CurrencySwapMember us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:InterestRateContractMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:InterestRateContractMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:InterestRateContractMember us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:InterestRateContractMember us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NondesignatedMember 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NondesignatedMember 2025-06-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:AccruedLiabilitiesMember us-gaap:NondesignatedMember 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:AccruedLiabilitiesMember us-gaap:NondesignatedMember 2025-06-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:OtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:OtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:CurrencySwapMember us-gaap:OtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:OtherAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2024-07-01 2024-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2025-07-01 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2024-07-01 2024-09-30 0001001250 us-gaap:CashFlowHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:CashFlowHedgingMember 2024-07-01 2024-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember 2024-07-01 2024-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2024-07-01 2024-09-30 0001001250 us-gaap:NetInvestmentHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:NetInvestmentHedgingMember 2024-07-01 2024-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2024-07-01 2024-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-07-01 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001001250 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2025-07-01 2025-09-30 0001001250 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2024-07-01 2024-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember 2025-07-01 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember 2024-07-01 2024-09-30 0001001250 us-gaap:FairValueHedgingMember us-gaap:LongTermDebtMember 2025-07-01 2025-09-30 0001001250 us-gaap:FairValueHedgingMember el:LongTermDebtIntercompanyMember 2025-07-01 2025-09-30 0001001250 us-gaap:SalesMember 2025-07-01 2025-09-30 0001001250 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-07-01 2025-09-30 0001001250 us-gaap:InterestExpenseMember 2025-07-01 2025-09-30 0001001250 us-gaap:SalesMember 2024-07-01 2024-09-30 0001001250 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001001250 us-gaap:InterestExpenseMember 2024-07-01 2024-09-30 0001001250 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2025-07-01 2025-09-30 0001001250 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember us-gaap:InterestExpenseMember 2024-07-01 2024-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-07-01 2025-09-30 0001001250 us-gaap:CurrencySwapMember us-gaap:FairValueHedgingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-07-01 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-09-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-09-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-09-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-06-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-06-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-06-30 0001001250 us-gaap:FairValueMeasurementsRecurringMember 2025-06-30 0001001250 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2025-09-30 0001001250 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-30 0001001250 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2025-06-30 0001001250 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-06-30 0001001250 srt:AmericasMember 2025-07-01 2025-09-30 0001001250 srt:AmericasMember 2024-07-01 2024-09-30 0001001250 el:EuropeUnitedKingdomAndIrelandAndEmergingMarketsMember 2025-07-01 2025-09-30 0001001250 el:EuropeUnitedKingdomAndIrelandAndEmergingMarketsMember 2024-07-01 2024-09-30 0001001250 srt:AsiaPacificMember 2025-07-01 2025-09-30 0001001250 srt:AsiaPacificMember 2024-07-01 2024-09-30 0001001250 el:MainlandChinaMember 2025-07-01 2025-09-30 0001001250 el:MainlandChinaMember 2024-07-01 2024-09-30 0001001250 el:ReturnsAssociatedWithRestructuringAndOtherActivitiesMember 2025-07-01 2025-09-30 0001001250 el:ReturnsAssociatedWithRestructuringAndOtherActivitiesMember 2024-07-01 2024-09-30 0001001250 2025-10-01 2025-09-30 0001001250 us-gaap:LicenseMember el:MarcolinGroupMember 2026-10-01 2025-09-30 0001001250 us-gaap:LicenseMember el:MarcolinGroupMember 2023-04-28 2025-09-30 0001001250 country:US us-gaap:PensionPlansDefinedBenefitMember 2025-07-01 2025-09-30 0001001250 country:US us-gaap:PensionPlansDefinedBenefitMember 2024-07-01 2024-09-30 0001001250 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2025-07-01 2025-09-30 0001001250 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2024-07-01 2024-09-30 0001001250 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2025-07-01 2025-09-30 0001001250 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-07-01 2024-09-30 0001001250 2023-12-07 2024-01-22 0001001250 2024-02-20 2024-02-20 0001001250 2025-05-08 2025-05-08 0001001250 2025-09-15 2025-09-26 0001001250 el:CosmeticTalcumPowderMattersMember 2025-09-30 0001001250 el:CosmeticTalcumPowderMattersMember 2025-06-30 0001001250 el:CosmeticTalcumPowderMattersMember 2025-07-01 2025-09-30 0001001250 el:CosmeticTalcumPowderMattersMember 2024-10-31 2024-10-31 0001001250 us-gaap:CommonClassAMember 2025-07-01 2025-09-30 0001001250 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2025-07-01 2025-09-30 0001001250 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember el:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodOneMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2025-07-01 2025-09-30 0001001250 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember el:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodTwoMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2025-07-01 2025-09-30 0001001250 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonClassAMember el:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingPeriodThreeMember us-gaap:ShareBasedPaymentArrangementEmployeeMember 2025-07-01 2025-09-30 0001001250 el:LongTermPerformanceSharesMember us-gaap:CommonClassAMember el:FormerChiefExecutiveOfficerMember 2025-09-02 2025-09-02 0001001250 el:LongTermPerformanceSharesMember us-gaap:CommonClassAMember el:FormerChiefExecutiveOfficerMember 2024-09-03 2024-09-03 0001001250 el:LongTermPriceVestedUnitsMember us-gaap:CommonClassAMember el:FormerChiefExecutiveOfficerMember 2025-09-02 2025-09-02 0001001250 us-gaap:EmployeeStockOptionMember 2025-07-01 2025-09-30 0001001250 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0001001250 us-gaap:PerformanceSharesMember 2025-07-01 2025-09-30 0001001250 us-gaap:PerformanceSharesMember 2024-07-01 2024-09-30 0001001250 us-gaap:RestrictedStockUnitsRSUMember 2025-07-01 2025-09-30 0001001250 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0001001250 us-gaap:EmployeeStockOptionMember 2025-07-01 2025-09-30 0001001250 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0001001250 el:RestrictedStockUnitsAndPerformanceSharesMember 2025-07-01 2025-09-30 0001001250 el:RestrictedStockUnitsAndPerformanceSharesMember 2024-07-01 2024-09-30 0001001250 us-gaap:PerformanceSharesMember us-gaap:CommonClassAMember 2025-07-01 2025-09-30 0001001250 us-gaap:PerformanceSharesMember us-gaap:CommonClassAMember 2024-07-01 2024-09-30 0001001250 us-gaap:CommonStockMember 2025-06-30 0001001250 us-gaap:CommonStockMember 2024-06-30 0001001250 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001001250 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001001250 us-gaap:CommonStockMember 2025-09-30 0001001250 us-gaap:CommonStockMember 2024-09-30 0001001250 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001001250 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001001250 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001001250 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001001250 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001001250 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001001250 us-gaap:RetainedEarningsMember 2025-06-30 0001001250 us-gaap:RetainedEarningsMember 2024-06-30 0001001250 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001001250 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001001250 us-gaap:RetainedEarningsMember 2025-09-30 0001001250 us-gaap:RetainedEarningsMember 2024-09-30 0001001250 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001001250 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001001250 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001001250 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001001250 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001001250 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001001250 us-gaap:TreasuryStockCommonMember 2025-06-30 0001001250 us-gaap:TreasuryStockCommonMember 2024-06-30 0001001250 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0001001250 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0001001250 us-gaap:TreasuryStockCommonMember 2025-09-30 0001001250 us-gaap:TreasuryStockCommonMember 2024-09-30 0001001250 us-gaap:ParentMember 2025-09-30 0001001250 us-gaap:ParentMember 2024-09-30 0001001250 us-gaap:CommonClassBMember 2025-07-01 2025-09-30 0001001250 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2025-10-29 2025-10-29 0001001250 us-gaap:CommonClassBMember us-gaap:SubsequentEventMember 2025-10-29 2025-10-29 0001001250 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-06-30 0001001250 el:AccumulatedGainLossNetFairValueHedgeContractParentMember 2025-06-30 0001001250 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-06-30 0001001250 us-gaap:AccumulatedTranslationAdjustmentMember 2025-06-30 0001001250 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-07-01 2025-09-30 0001001250 el:AccumulatedGainLossNetFairValueHedgeContractParentMember 2025-07-01 2025-09-30 0001001250 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-07-01 2025-09-30 0001001250 us-gaap:AccumulatedTranslationAdjustmentMember 2025-07-01 2025-09-30 0001001250 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-09-30 0001001250 el:AccumulatedGainLossNetFairValueHedgeContractParentMember 2025-09-30 0001001250 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-09-30 0001001250 us-gaap:AccumulatedTranslationAdjustmentMember 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-07-01 2025-09-30 0001001250 us-gaap:ForeignExchangeForwardMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2024-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-07-01 2025-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2024-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember el:AccumulatedGainLossNetFairValueHedgeContractParentMember 2025-07-01 2025-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember el:AccumulatedGainLossNetFairValueHedgeContractParentMember 2024-07-01 2024-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2025-07-01 2025-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2024-07-01 2024-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2025-07-01 2025-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2024-07-01 2024-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-07-01 2025-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-07-01 2024-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001001250 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001001250 us-gaap:ProductAndServiceOtherMember 2025-07-01 2025-09-30 0001001250 el:RestructuringAndRelatedCostIncurredCostMember 2025-07-01 2025-09-30 0001001250 us-gaap:ProductAndServiceOtherMember 2024-07-01 2024-09-30 0001001250 el:SkinCareMember 2024-07-01 2024-09-30 0001001250 el:MakeupMember 2024-07-01 2024-09-30 0001001250 el:FragranceMember 2024-07-01 2024-09-30 0001001250 el:HairCareMember 2024-07-01 2024-09-30 0001001250 el:RestructuringAndRelatedCostIncurredCostMember 2024-07-01 2024-09-30
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________________________________
FORM 10-Q
(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025
or

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission file number 1-14064
The Estée Lauder Companies Inc.
(Exact name of registrant as specified in its charter)

Delaware | 11-2408943
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)
767 Fifth Avenue, New York, New York | 10153
(Address of principal executive offices) | (Zip Code)

212-572-4200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Class A Common Stock, $.01 par value | EL | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
At October 23, 2025, 234,818,211 shares of the registrant’s Class A Common Stock, $.01 par value, and 125,542,029 shares of the registrant’s Class B Common Stock, $.01 par value, were outstanding.

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
INDEX

| Page
Part I. Financial Information |
Item 1. Financial Statements (Unaudited) |
Consolidated Statements of Earnings (Loss) — Three Months Ended September 30, 2025 and 2024 | 2
Consolidated Statements of Comprehensive Incom e (Loss) — Three Months Ended September 30, 2025 and 2024 | 3
Consolidated Balance Sheets — September 30, 2025 and June 30, 2025 | 4
Consolidated Statements of Cash Flows — Three Months Ended September 30, 2025 and 2024 | 5
Notes to Consolidated Financial Statements | 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 33
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 54
Item 4. Controls and Procedures | 55
Part II. Other Information |
Item 1. Legal Proceedings | 55
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 55
Item 5. Other Information | 56
Item 6. Exhibits | 56
Signatures | 57

Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
(Unaudited)

|  |  |  |  |  | Three Months Ended September 30,
(In millions, except per share data) |  |  |  |  |  |  |  |  |  | 2025 |  | 2024
Net sales |  |  |  |  |  |  |  |  |  | $ | 3,481 |  |  | $ | 3,361 |
Cost of sales |  |  |  |  |  |  |  |  |  | 927 |  |  | 928 |
Gross profit |  |  |  |  |  |  |  |  |  | 2,554 |  |  | 2,433 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |
Selling, general and administrative |  |  |  |  |  |  |  |  |  | 2,296 |  |  | 2,298 |
Restructuring and other charges |  |  |  |  |  |  |  |  |  | 89 |  |  | 97 |
Talcum litigation settlement agreements |  |  |  |  |  |  |  |  |  | — |  |  | 159 |
Total operating expenses |  |  |  |  |  |  |  |  |  | 2,385 |  |  | 2,554 |
Operating income (loss) |  |  |  |  |  |  |  |  |  | 169 |  |  | (121) |
Interest expense |  |  |  |  |  |  |  |  |  | 86 |  |  | 92 |
Interest income and investment income, net |  |  |  |  |  |  |  |  |  | 30 |  |  | 35 |
Other components of net periodic benefit cost |  |  |  |  |  |  |  |  |  | 4 |  |  | 2 |
Earnings (loss) before income taxes |  |  |  |  |  |  |  |  |  | 109 |  |  | (180) |
Provision (benefit) for income taxes |  |  |  |  |  |  |  |  |  | 62 |  |  | (24) |
Net earnings (loss) |  |  |  |  |  |  |  |  |  | $ | 47 |  |  | $ | (156) |
Net earnings (loss) per common share |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  |  |  |  |  |  |  |  | $ | .13 |  |  | $ | (.43) |
Diluted |  |  |  |  |  |  |  |  |  | $ | .13 |  |  | $ | (.43) |
Weighted average common shares outstanding |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  |  |  |  |  |  |  |  | 361.2 |  |  | 359.6 |
Diluted |  |  |  |  |  |  |  |  |  | 363.3 |  |  | 359.6 |

See notes to consolidated financial statements.
2

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)

|  |  |  |  | Three Months Ended September 30, |  |
(In millions) |  |  |  |  |  |  | 2025 |  | 2024 |  |  |  |
Net earnings (loss) |  |  |  |  |  |  | $ | 47 |  |  | $ | (156) |  |  |  |  |
Other comprehensive (loss) income: |  |  |  |  |  |  |  |  |  |  |  |  |
Net cash flow hedge gain (loss) |  |  |  |  |  |  | 16 |  |  | (57) |  |  |  |  |
Cross-currency swap contract - fair value hedge gain |  |  |  |  |  |  | 3 |  |  | 12 |  |  |  |  |
Retirement plan and other retiree benefit adjustments |  |  |  |  |  |  | 4 |  |  | 2 |  |  |  |  |
Translation adjustments |  |  |  |  |  |  | (27) |  |  | 108 |  |  |  |  |
(Provision) benefit for income taxes on components of other comprehensive (loss) income |  |  |  |  |  |  | (10) |  |  | 18 |  |  |  |  |
Total other comprehensive (loss) income, net of tax |  |  |  |  |  |  | (14) |  |  | 83 |  |  |  |  |
Comprehensive income (loss) |  |  |  |  |  |  | $ | 33 |  |  | $ | (73) |  |  |  |  |

See notes to consolidated financial statements.
3

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)

(In millions, except share and per share data) |  | September 30, 2025 |  | June 30, 2025
ASSETS |  |  |  |
Current assets |  |  |  |
Cash and cash equivalents |  | $ | 2,219 |  |  | $ | 2,921 |
Accounts receivable, net |  | 1,884 |  |  | 1,530 |
Inventory and promotional merchandise |  | 2,062 |  |  | 2,074 |
Prepaid expenses and other current assets |  | 549 |  |  | 544 |
Total current assets |  | 6,714 |  |  | 7,069 |
Property, plant and equipment, net |  | 3,065 |  |  | 3,172 |
Other assets |  |  |  |
Operating lease right-of-use assets |  | 1,889 |  |  | 1,952 |
Goodwill |  | 2,119 |  |  | 2,135 |
Other intangible assets, net |  | 3,706 |  |  | 3,759 |
Other assets |  | 1,836 |  |  | 1,805 |
Total other assets |  | 9,550 |  |  | 9,651 |
Total assets |  | $ | 19,329 |  |  | $ | 19,892 |
LIABILITIES AND EQUITY |  |  |  |
Current liabilities |  |  |  |
Current debt |  | $ | 3 |  |  | $ | 3 |
Accounts payable |  | 1,289 |  |  | 1,497 |
Operating lease liabilities |  | 415 |  |  | 406 |
Other accrued liabilities |  | 3,376 |  |  | 3,529 |
Total current liabilities |  | 5,083 |  |  | 5,435 |
Noncurrent liabilities |  |  |  |
Long-term debt |  | 7,320 |  |  | 7,314 |
Long-term operating lease liabilities |  | 1,684 |  |  | 1,744 |
Other noncurrent liabilities |  | 1,352 |  |  | 1,534 |
Total noncurrent liabilities |  | 10,356 |  |  | 10,592 |
Commitments and contingencies |  |  |  |
Equity |  |  |  |
Common stock, $.01 par value; Class A shares authorized: 1,300,000,000 at September 30, 2025 and June 30, 2025; shares issued: 473,216,446 at September 30, 2025 and 472,541,563 at June 30, 2025; Class B shares authorized: 304,000,000 at September 30, 2025 and June 30, 2025; shares issued and outstanding: 125,542,029 at September 30, 2025 and June 30, 2025 |  | 6 |  |  | 6 |
Paid-in capital |  | 7,141 |  |  | 7,012 |
Retained earnings |  | 11,591 |  |  | 11,672 |
Accumulated other comprehensive loss |  | (1,141) |  |  | (1,127) |
|  | 17,597 |  |  | 17,563 |
Less: Treasury stock, at cost; 238,401,382 Class A shares at September 30, 2025 and 238,316,738 Class A shares at June 30, 2025 |  | (13,707) |  |  | (13,698) |
Total equity |  | 3,890 |  |  | 3,865 |
Total liabilities and equity |  | $ | 19,329 |  |  | $ | 19,892 |

See notes to consolidated financial statements.
4

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

|  | Three Months Ended September 30,
(In millions) |  | 2025 |  | 2024
Cash flows from operating activities |  |  |  |
Net earnings (loss) |  | $ | 47 |  |  | $ | (156) |
Adjustments to reconcile net earnings (loss) to net cash flows from operating activities: |  |  |  |
Depreciation and amortization |  | 200 |  |  | 208 |
Deferred income taxes |  | (34) |  |  | (79) |
Non-cash stock-based compensation |  | 88 |  |  | 74 |
Net loss on disposal of property, plant and equipment |  | — |  |  | 1 |
Non-cash restructuring and other charges |  | 3 |  |  | 11 |
Pension and post-retirement benefit expense |  | 21 |  |  | 18 |
Pension and post-retirement benefit contributions |  | (28) |  |  | (32) |
Other adjustments and non-cash items |  | (2) |  |  | 1 |
Changes in operating assets and liabilities: |  |  |  |
Increase in accounts receivable, net |  | (358) |  |  | (219) |
Decrease (increase) in inventory and promotional merchandise |  | 6 |  |  | (10) |
Increase in other assets, net |  | (11) |  |  | (47) |
Decrease in accounts payable |  | (204) |  |  | (337) |
Decrease in other accrued and noncurrent liabilities |  | (79) |  |  | (100) |
Increase (decrease) in operating lease assets and liabilities, net |  | 11 |  |  | (3) |
Net cash flows used for operating activities |  | (340) |  |  | (670) |
Cash flows from investing activities |  |  |  |
Purchases of investments |  | — |  |  | (1) |
Capital expenditures |  | (96) |  |  | (141) |
Proceeds from the disposition of investments |  | 3 |  |  | — |
Settlement of net investment hedges |  | (23) |  |  | (18) |
Net cash flows used for investing activities |  | (116) |  |  | (160) |
Cash flows from financing activities |  |  |  |
Repayments of long-term debt |  | (1) |  |  | (1) |
Settlement of cross-currency swaps |  | 9 |  |  | 10 |
Net proceeds from stock-based compensation transactions |  | 39 |  |  | 15 |
Dividends paid to stockholders |  | (127) |  |  | (240) |
Payments to acquire treasury stock |  | (9) |  |  | (10) |
Payment of deferred consideration |  | (150) |  |  | — |
Net cash flows used for financing activities |  | (239) |  |  | (226) |
Effect of exchange rate changes on Cash and cash equivalents |  | (7) |  |  | 11 |
Net decrease in Cash and cash equivalents |  | (702) |  |  | (1,045) |
Cash and cash equivalents at beginning of period |  | 2,921 |  |  | 3,395 |
Cash and cash equivalents at end of period |  | $ | 2,219 |  |  | $ | 2,350 |

See notes to consolidated financial statements.
5

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated.
The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP in annual financial statements. The unaudited interim consolidated financial statements reflect all normal and recurring adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Certain prior-year amounts in the notes to the consolidated financial statements have been reclassified to conform to current-year presentation.
Management Estimates
The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Descriptions of the Company’s significant accounting policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. Management evaluates the related estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, as relevant, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions will be reflected in the consolidated financial statements in future periods.
Currency Translation and Transactions
All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at monthly average rates of exchange for the period. Unrealized translation (losses) gains, net of tax, reported as translation adjustments through other comprehensive income (loss) (“OCI”) were $(32) million and $115 million, net of tax, during the three months ended September 30, 2025 and 2024, respectively. For the Company’s subsidiaries operating in highly inflationary economies, the U.S. dollar is the functional currency, and these subsidiaries are not material to the Company's consolidated financial statements or liquidity as of and for the three months ended September 30, 2025 and 2024. Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings.
The Company enters into foreign currency forward contracts to hedge foreign currency transactions for periods consistent with its identified exposures. The Company also uses cross-currency swap contracts to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt. Additionally, the Company enters into foreign currency forward contracts to hedge a portion of its net investment in certain foreign operations, which are designated as net investment hedges. See Note 4 – Derivative Financial Instruments for further discussion. The Company categorizes these instruments as entered into for purposes other than trading.
The accompanying consolidated statements of earnings (loss) include net exchange (losses) gains on foreign currency transactions of $(6) million and $19 million during the three months ended September 30, 2025 and 2024, respectively.
6

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Concentration of Credit Risk
The Company is a worldwide manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. The Company’s sales subject to credit risk are made primarily to department stores, duty-free retailers, specialty multi retailers, online pure players, perfumeries and pharmacies, and salons and spas. The Company grants credit to qualified customers. While the Company does not believe it is exposed significantly to any undue concentration of credit risk at this time, it continues to monitor its customers' abilities, individually and collectively, to make timely payments.
Inventory and Promotional Merchandise
Inventory and promotional merchandise consists of the following:

(In millions) |  | September 30, 2025 |  | June 30, 2025
Raw materials |  | $ | 593 |  |  | $ | 631 |
Work in process |  | 250 |  |  | 283 |
Finished goods |  | 1,062 |  |  | 996 |
Promotional merchandise |  | 157 |  |  | 164 |
Total inventory and promotional merchandise |  | $ | 2,062 |  |  | $ | 2,074 |

Property, Plant and Equipment
Property, plant and equipment consists of the following:

($ in millions) |  | September 30, 2025 |  | June 30, 2025
Assets (Useful Life) |  |  |  |
Land and improvements(1) |  | $ | 74 |  |  | $ | 75 |
Buildings and improvements (10 to 40 years) |  | 1,051 |  |  | 1,057 |
Machinery and equipment (3 to 20 years) |  | 1,431 |  |  | 1,429 |
Computer hardware and software (4 to 10 years) |  | 2,077 |  |  | 1,926 |
Furniture and fixtures (5 to 10 years) |  | 143 |  |  | 145 |
Leasehold improvements |  | 2,646 |  |  | 2,631 |
Construction in progress |  | 319 |  |  | 462 |
Total property, plant and equipment, gross |  | 7,741 |  |  | 7,725 |
Less accumulated depreciation and amortization |  | (4,676) |  |  | (4,553) |
Total property, plant and equipment, net |  | $ | 3,065 |  |  | $ | 3,172 |

(1)Land improvements are depreciated over a 10 year useful life.
Depreciation and amortization of property, plant and equipment was $170 million and $168 million during the three months ended September 30, 2025 and 2024, respectively. Depreciation and amortization related to the Company’s manufacturing process is included in Cost of sales, and all other depreciation and amortization is included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings (loss).
Income Taxes
The effective rate for income taxes was 56.9% and 13.3% for the three months ended September 30, 2025 and 2024, respectively. The increase in the effective tax rate of 4,360 basis points was attributable in part to the loss before income taxes in the fiscal 2025 first quarter as well as the estimated unfavorable impact of the newly enacted U.S. tax legislation, a higher effective tax rate on the Company's foreign operations due to the Company's full year geographical mix of earnings in the current and prior-year periods and an unfavorable impact associated with the establishment of a valuation allowance against current period foreign tax credit and research and development tax credit U.S. deferred tax assets.
7

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On July 4, 2025, new U.S tax legislation was enacted known as the One Big Beautiful Bill Act. This legislation includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of certain business tax provisions. The legislation has multiple effective dates, with certain provisions becoming effective in fiscal 2026. The most impactful provision effective beginning in fiscal 2026 relates to the expansion of the business interest expense deduction limitation. The resulting increase in tax deductible interest expense reduced U.S. taxable income and increased the excess foreign tax credits generated which require a valuation allowance. The estimated unfavorable fiscal 2026 impact of the One Big Beautiful Bill Act has been included in the provision for income taxes, and the impact for the three months ended September 30, 2025 was $8 million.
In December 2021, the Organization for Economic Cooperation and Development issued "Pillar Two" Global Anti-Base Erosion model rules for countries to enact into domestic law that would establish a 15% global minimum tax applied on a country-by-country basis for multinational companies. In certain countries that have enacted legislation incorporating the global minimum tax, it became effective for the Company at the beginning of fiscal 2025. The estimated tax impact of such legislation has been included in the provision for income taxes for the three months ended September 30, 2025 and was not material.
As of September 30, 2025 and June 30, 2025, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $141 million and $140 million, respectively. The total amount of unrecognized tax benefits at September 30, 2025 that, if recognized, would affect the effective tax rate was $134 million. The total gross interest and penalties accrued related to unrecognized tax benefits during the three months ended September 30, 2025 in the accompanying consolidated statements of earnings (loss) was $2 million. The total gross accrued interest and penalties in the accompanying consolidated balance sheets at September 30, 2025 and June 30, 2025, was $21 million and $19 million, respectively. On the basis of the information available as of September 30, 2025, the Company does not expect significant changes to the total amount of unrecognized tax benefits within the next twelve months.
At September 30, 2025 and June 30, 2025, total Other assets of $1,836 million and $1,805 million included $1,366 million and $1,339 million of deferred tax assets, respectively.
Supplier Finance Programs
Under its supplier finance programs, the Company agrees to pay the banks the stated amount of confirmed invoices from its designated suppliers on the due dates of the invoices. The Company may terminate the agreements upon written notice (with notice periods ranging from 30 to 60 days) or immediately upon a breach. The supplier invoices that have been confirmed as valid under the programs require payment in full within 90 days of the invoice date.
Outstanding obligations confirmed as valid totaling $65 million and $82 million as of September 30, 2025 and June 30, 2025, respectively, are included in Accounts payable in the accompanying consolidated balance sheets.
Other Accrued Liabilities
Other accrued liabilities consist of the following:

(In millions) |  | September 30, 2025 |  | June 30, 2025
Accrued employee compensation |  | $ | 432 |  |  | $ | 551 |
Accrued income taxes |  | 200 |  |  | 282 |
Accrued payroll and other non-income taxes |  | 351 |  |  | 307 |
Accrued restructuring |  | 292 |  |  | 279 |
Accrued sales incentives |  | 318 |  |  | 321 |
Accrued selling, advertising, marketing, promotion and product development |  | 311 |  |  | 287 |
Deferred revenue |  | 332 |  |  | 314 |
Sales return accrual |  | 267 |  |  | 255 |
Other |  | 873 |  |  | 933 |
Total other accrued liabilities |  | $ | 3,376 |  |  | $ | 3,529 |

8

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Recently Issued Accounting Standards
FASB ASU No. 2025-06 – Targeted Improvements to the Accounting for Internal-Use Software (Subtopic 350-40)
In September 2025, the FASB issued authoritative guidance to modernize the accounting for the costs to develop software for internal use to align better with current software development methods, such as agile programming. Capitalization of eligible costs will begin when (1) management has authorized and committed to funding the software project, and (2) it is probable that the project will be completed and the software will be used to perform the function intended. In evaluating whether it is probable the project will be completed, entities are required to consider whether there is significant uncertainty associated with the development activities of the software. The new standard does not change the types of costs that are capitalizable once the threshold for capitalization is met. Capitalization ceases when the software project is substantially complete and ready for its intended use, which typically occurs after all substantial testing is completed. Furthermore, the guidance supersedes website development costs guidance and incorporates the recognition requirements for website-specific development costs into Subtopic 350-40. The guidance clarifies that existing disclosure requirements under ASC 360 for property, plant and equipment apply to capitalized costs under the new standard, regardless of how the internal-use software is classified on the balance sheet or how it was acquired.
Effective for the Company: The guidance becomes effective for the Company’s first quarter of fiscal 2029. The guidance can be applied prospectively, retrospectively or through a modified transition approach. Early adoption is permitted.
Impact on consolidated financial statements: The Company is currently evaluating the impact that this guidance will have on its consolidated financial statements.
FASB ASU No. 2025-05 – Measurement of Credit Losses for Accounts Receivable and Contract Assets (Topic 326)
In July 2025, the FASB issued authoritative guidance related to the estimation of expected credit losses for current accounts receivable and current contract assets. The guidance allows entities to elect a practical expedient to assume that current conditions as of the balance sheet date do not change for the remaining life of the asset in the development of a reasonable and supportable forecast as part of estimating expected credit losses. Entities electing the practical expedient are still required to adjust historical loss information to reflect current conditions to the extent that historical loss information does not reflect current conditions. An entity that elects to use the practical expedient is required to disclose that fact.
Effective for the Company: The guidance becomes effective for the Company’s first quarter of fiscal 2027 and is applied prospectively. Early adoption is permitted.
Impact on consolidated financial statements: The Company is currently evaluating the impact that this guidance will have on its accounts receivable balance and consolidated financial statement disclosures.
FASB ASU No. 2024-03 and 2025-01 – Disaggregation of Income Statement Expenses (Subtopic 220-40)
In November 2024 and January 2025, the FASB issued authoritative guidance requiring disclosures, in a tabular format in the notes to the consolidated financial statements, on the disaggregation of relevant expense captions that are included on the face of the consolidated statement of earnings (loss) within continuing operations. The relevant expense captions are required to be disaggregated into natural expense categories including purchases of inventory, employee compensation, depreciation and intangible asset amortization. The guidance also requires certain expenses, gains or losses that require disclosure under existing U.S. GAAP, and that are recorded in a relevant expense caption on the face of the consolidated statement of earnings (loss), to be presented in the same tabular disclosure. Qualitative disclosures about any remaining amounts in relevant expense line items are required as well. In addition, companies are required to disclose the total amount of selling expenses and, on an annual basis, how it defines selling expenses.
Effective for the Company: The guidance is effective for the Company’s fiscal year ending June 30, 2028 Form 10-K and then in interim periods beginning in the Company’s first quarter of fiscal 2029. Early adoption is permitted. The guidance should be applied on a prospective basis; however, retrospective application is permitted.
Impact on consolidated financial statements: The Company is currently evaluating the impact that this guidance will have on its consolidated financial statement disclosures.
FASB ASU No. 2023-09 – Income Taxes (Topic 740): Improvements to Income Tax Disclosures
In December 2023, the FASB issued authoritative guidance to amend and enhance existing annual in come tax disclosures primarily focusing on two reporting areas: (1) greater disaggregation of information in the effective tax rate reconciliations and (2) disclosure of income taxes paid, disaggregated by applicable jurisdiction.
9

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Companies are required to use specific categories to prepare and disclose a tabular rate reconciliation (using both percentages and reporting currency amounts) of:
•the reported income tax expense (or benefit) from continuing operations and the product of the income (or loss) from continuing operations before income taxes and the applicable statutory federal income tax rate of the jurisdiction of domicile; and
•reconciling items within certain categories that are equal to or greater than a specified quantitative threshold, including the nature, effect, and underlying causes of the reconciling items and the judgment used in categorizing the reconciling items.
The guidance also requires companies to disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state, and foreign jurisdictions including individual jurisdictions with amounts paid equal to or greater than a specified quantitative threshold. The guidance also codifies existing SEC rules that require companies to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign as well as income tax expense (or benefit) from continuing operations disaggregated by federal, state, and foreign jurisdictions.
Effective for the Company – The guidance is effective for the Company’s fiscal year ending June 30, 2026 Form 10-K. Early adoption is permitted. The guidance should be applied on a prospective basis with the option to apply the standard retrospectively.
Impact on consolidated financial statement s – The Company is currently evaluating the impact that this guidance will have on its consolidated financial statement disclosures.
NOTE 2 – GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The Company assigns goodwill at the time of acquisition to a reporting unit, which is one level below the Company's operating segments. The skin care, makeup, fragrance and hair care product categories are the Company's operating segments.
The following table presents goodwill by product category and the related change in the carrying amount:

(In millions) |  | Skin Care |  | Makeup |  | Fragrance |  | Hair Care |  | Total
Balance as of June 30, 2025 |  |  |  |  |  |  |  |  |  |
Goodwill |  | $ | 1,616 |  |  | $ | 1,116 |  |  | $ | 260 |  |  | $ | 353 |  |  | $ | 3,345 |
Accumulated impairments |  | (435) |  |  | (745) |  |  | (30) |  |  | — |  |  | (1,210) |
|  | 1,181 |  |  | 371 |  |  | 230 |  |  | 353 |  |  | 2,135 |
Translation adjustments, goodwill |  | (24) |  |  | — |  |  | — |  |  | — |  |  | (24) |
Translation adjustments, accumulated impairments |  | 8 |  |  | — |  |  | — |  |  | — |  |  | 8 |
|  | (16) |  |  | — |  |  | — |  |  | — |  |  | (16) |
Balance as of September 30, 2025 |  |  |  |  |  |  |  |  |  |
Goodwill |  | 1,592 |  |  | 1,116 |  |  | 260 |  |  | 353 |  |  | 3,321 |
Accumulated impairments |  | (427) |  |  | (745) |  |  | (30) |  |  | — |  |  | (1,202) |
Total goodwill |  | $ | 1,165 |  |  | $ | 371 |  |  | $ | 230 |  |  | $ | 353 |  |  | $ | 2,119 |

10

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Other Intangible Assets
Other intangible assets consist of the following:

|  | September 30, 2025 |  | June 30, 2025
(In millions) |  | Gross Carrying Value |  | Accumulated Amortization |  | Total Net Book Value |  | Gross Carrying Value |  | Accumulated Amortization |  | Total Net Book Value
Amortizable intangible assets: |  |  |  |  |  |  |  |  |  |  |  |
Customer lists and other |  | $ | 1,954 |  |  | $ | 1,355 |  |  | $ | 599 |  |  | $ | 1,984 |  |  | $ | 1,348 |  |  | $ | 636 |
Non-amortizable intangible assets: |  |  |  |  |  |  |  |  |  |  |  |
Trademarks |  |  |  |  |  | 3,107 |  |  |  |  |  |  | 3,123 |
Total other intangible assets, net |  |  |  |  |  | $ | 3,706 |  |  |  |  |  |  | $ | 3,759 |

The aggregate amortization expense related to amortizable intangible assets was $26 million and $36 million for the three months ended September 30, 2025 and 2024, respectively.
The estimated aggregate amortization expense for the remainder of fiscal 2026 and for each of the next four fiscal years is as follows:

|  | Fiscal
(In millions) |  | 2026 |  | 2027 |  | 2028 |  | 2029 |  | 2030
Estimated aggregate amortization expense |  | $ | 78 |  |  | $ | 87 |  |  | $ | 71 |  |  | $ | 69 |  |  | $ | 67 |

NOTE 3 – CHARGES ASSOCIATED WITH RESTRUCTURING AND OTHER ACTIVITIES
Restructuring Program Component of the Profit Recovery and Growth Plan
As announced on November 1, 2023, the Company launched the Profit Recovery and Growth Plan ("PRGP") to help progressively rebuild its profit margins in fiscal years 2025 and 2026.
As a component of the PRGP, on February 5, 2024, the Company announced a two-year restructuring program. The Company committed to this course of action on February 1, 2024.
After reviewing additional potential initiatives and the progress of previously approved initiatives, on February 3, 2025, the Company committed to the expansion of the PRGP, including an expansion of the restructuring program.
The expanded component of the restructuring program began during the Company’s fiscal 2025 third quarter. The focus of the overall expanded restructuring program (collectively the “Restructuring Program”) includes (i) reorganization and rightsizing of certain areas, (ii) simplification and acceleration of processes, (iii) outsourcing of select services and (iv) evolution of go-to-market footprint and selling models. Cumulative initiatives under the Restructuring Program are expected to be approved by the end of fiscal 2026 and substantially completed by the end of fiscal 2027.
In connection with the Restructuring Program, as of September 30, 2025, the Company estimates a net reduction in the range of approximately 5,800 to 7,000 positions globally, which is about 9-11% of its positions including temporary and part-time employees as of June 30, 2023. This net reduction takes into account the elimination of positions after retraining and redeployment of certain employees in select areas.
The Company expects that the Restructuring Program will result in restructuring and other charges totaling between $1,200 million and $1,600 million, before taxes, consisting of employee-related costs, asset-related costs, contract terminations and other costs associated with implementing these initiatives, which other than the non-cash charges, are expected to result in future cash expenditures funded from cash provided by operations.
11

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Additional information relating to the Company's Profit Recovery and Growth Plan and related Restructuring Program is included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Restructuring Program Approvals
Cumulative charges for initiatives approved by the Company in connection with the Restructuring Program as of September 30, 2025 and through October 26, 2025, were:

|  | Sales Returns (included in Net Sales) |  | Cost of Sales |  | Operating Expenses |  | Total
(In millions) |  |  |  | Restructuring Charges |  | Other Charges |
Total Charges Approved |  |  |  |  |  |  |  |  |  |
Cumulative charges approved through June 30, 2025 |  | $ | 4 |  |  | $ | 10 |  |  | $ | 552 |  |  | $ | 114 |  |  | $ | 680 |
Three months ended September 30, 2025 |  | 1 |  |  | — |  |  | 107 |  |  | 39 |  |  | 147 |
Cumulative charges approved through September 30, 2025 |  | 5 |  |  | 10 |  |  | 659 |  |  | 153 |  |  | 827 |
October 1, 2025 - October 26, 2025 |  | (1) |  |  | — |  |  | 24 |  |  | 2 |  |  | 25 |
Cumulative charges approved through October 26, 2025 |  | $ | 4 |  |  | $ | 10 |  |  | $ | 683 |  |  | $ | 155 |  |  | $ | 852 |

Included in the above table, cumulative restructuring charges for initiatives approved by the Company in connection with the Restructuring Program as of September 30, 2025 and through October 26, 2025, by major cost type were:

(In millions) |  | Employee- Related Costs |  | Asset- Related Costs |  | Contract Terminations |  | Other Exit Costs |  | Total
Restructuring Charges Approved |  |  |  |  |  |  |  |  |  |
Cumulative charges approved through June 30, 2025 |  | $ | 512 |  |  | $ | 14 |  |  | $ | 3 |  |  | $ | 23 |  |  | $ | 552 |
Three months ended September 30, 2025 |  | 64 |  |  | 39 |  |  | 1 |  |  | 3 |  |  | 107 |
Cumulative charges approved through September 30, 2025 |  | 576 |  |  | 53 |  |  | 4 |  |  | 26 |  |  | 659 |
October 1, 2025 - October 26, 2025 |  | 23 |  |  | — |  |  | — |  |  | 1 |  |  | 24 |
Cumulative charges approved through October 26, 2025 |  | $ | 599 |  |  | $ | 53 |  |  | $ | 4 |  |  | $ | 27 |  |  | $ | 683 |

Specific actions taken since the Restructuring Program inception to drive future sales growth and productivity to rebuild gross and operating margin profitability include:
•Value Chain Optimization – The Company approved initiatives to reduce spans and layers and right-size organizational capability within its supply chain and research and development functions. These actions will primarily result in employee severance through a net reduction in workforce, as well as asset-related costs and costs to decommission and relocate activities.
•Enabling Function Re-Invention – The Company approved initiatives to reorganize and right-size various corporate functions. These activities will primarily result in employee severance through a net reduction in workforce.
•Future of Brand-led Model – The Company approved initiatives to redesign spans and layers in its marketing, creative and other functions within the brand and product category structures to make them leaner, faster and more agile. These activities will primarily result in employee severance through a net reduction in workforce.
•Go-to-Market Operating Model Acceleration – The Company approved initiatives to optimize and right-size the organizational structure within its geographic regions to drive greater efficiency and effectiveness, as well as exit unprofitable brands from specific markets and distribution channels. These activities will primarily result in employee severance through a net reduction in workforce, inventory write-offs, as well as costs associated with sales returns.
12

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
•Digital Organization Transformation – The Company approved initiatives to begin to reorganize and right-size its technology functions, which support its internal enterprise and commercial capabilities, to create a leaner, faster, more effective and more agile technology organization. These activities will primarily result in employee severance through a net reduction in workforce, as well as asset-related costs.
Once the relevant accounting criteria have been met, the Company expects to record cumulative restructuring and other charges of approximately $852 million (before tax) in connection with these initiatives, which other than the non-cash charges, are expected to result in future cash expenditures funded from cash provided by operations.
Restructuring Program Restructuring and Other Charges
The Company classifies restructuring charges as follows:
Employee-Related Costs – Employee-related costs are primarily comprised of severance and other post-employment benefit costs, calculated based on salary levels, prior service and other statutory minimum benefits, if applicable.
Asset-Related Costs – Asset-related costs primarily consist of asset write-offs or accelerated depreciation related to long-lived assets (including operating lease right-of-use assets) that will be taken out of service prior to their existing useful life as a direct result of a restructuring initiative.
Contract Terminations – Costs related to contract terminations include continuing payments to a third party after the Company has ceased benefiting from the rights conveyed in the contract, or a payment made to terminate a contract prior to its expiration.
Other Exit Costs – Other exit costs related to restructuring activities generally include costs to relocate facilities or employees, recruiting to fill positions as a result of relocation of operations, and outplacement for separated employees.
The Company classifies other charges associated with restructuring activities as follows:
Sales Returns and Cost of Sales – Product returns (offset by the related cost of sales) and inventory write-offs or write-downs as a direct result of an approved restructuring initiative to exit certain businesses or locations will be recorded as a component of Net sales and/or Cost of sales when estimable and reasonably assured.
Other Charges – Other charges related to the design and implementation of approved initiatives, which are charged to Operating expenses as incurred and primarily include the following:
•Consulting and other professional services for organizational design of the future structures and processes as well as the implementation thereof;
•Temporary labor backfill;
•Costs to establish and maintain a Project Management Office for the duration of the Restructuring Program, including internal costs for employees dedicated solely to project management activities, and consulting services to assist with business case development and execution; and
•Recruitment and training costs for new and reskilled employees to acquire and apply the capabilities needed to perform responsibilities as a direct result of an approved restructuring initiative.
The Company records approved charges associated with restructuring and other activities once the relevant accounting criteria have been met.
13

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Total cumulative charges recorded associated with restructuring and other activities for the Restructuring Program were:

|  | Sales Returns (included in Net Sales) |  | Cost of Sales |  | Operating Expenses |  | Total
(In millions) |  |  |  | Restructuring Charges |  | Other Charges |
Total Charges |  |  |  |  |  |  |  |  |  |
Cumulative charges through June 30, 2025 |  | $ | — |  |  | $ | 9 |  |  | $ | 524 |  |  | $ | 77 |  |  | $ | 610 |
Three months ended September 30, 2025 |  | — |  |  | (2) |  |  | 72 |  |  | 17 |  |  | 87 |
Cumulative charges through September 30, 2025 |  | $ | — |  |  | $ | 7 |  |  | $ | 596 |  |  | $ | 94 |  |  | $ | 697 |

Included in the above table, cumulative restructuring charges recorded by the Company in connection with the Restructuring Program as of September 30, 2025, by major cost type were:

(In millions) |  | Employee- Related Costs |  | Asset- Related Costs |  | Contract Terminations |  | Other Exit Costs |  | Total
Restructuring Charges |  |  |  |  |  |  |  |  |  |
Cumulative charges through June 30, 2025 |  | $ | 503 |  |  | $ | 13 |  |  | $ | 3 |  |  | $ | 5 |  |  | $ | 524 |
Three months ended September 30, 2025 |  | 66 |  |  | 5 |  |  | — |  |  | 1 |  |  | 72 |
Cumulative charges through September 30, 2025 |  | $ | 569 |  |  | $ | 18 |  |  | $ | 3 |  |  | $ | 6 |  |  | $ | 596 |

Changes in accrued restructuring charges from the Restructuring Program for the three months ended September 30, 2025 were:

(In millions) |  | Employee- Related Costs |  | Asset- Related Costs |  | Contract Terminations |  | Other Exit Costs |  | Total
Balance at June 30, 2025 |  | $ | 369 |  |  | $ | — |  |  | $ | 2 |  |  | $ | — |  |  | $ | 371 |
Charges |  | 66 |  |  | 5 |  |  | — |  |  | 1 |  |  | 72 |
Cash payments |  | (66) |  |  | — |  |  | — |  |  | (1) |  |  | (67) |
Non-cash asset-related costs |  | — |  |  | (5) |  |  | — |  |  | — |  |  | (5) |
Translation and other adjustments |  | (2) |  |  | — |  |  | — |  |  | — |  |  | (2) |
Balance at September 30, 2025 |  | $ | 367 |  |  | $ | — |  |  | $ | 2 |  |  | $ | — |  |  | $ | 369 |

Accrued restructuring charges at September 30, 2025 relating to the Restructuring Program are expected to result in cash expenditures funded from cash provided by operations of approximately $248 million, $104 million and $17 million for the remainder of fiscal 2026 and for fiscal 2027 and 2028, respectively.
Charges associated with restructuring and other activities are not allocated to the Company's product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business.
NOTE 4 – DERIVATIVE FINANCIAL INSTRUMENTS
The Company addresses certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. The Company does not utilize derivative financial instruments for trading or speculative purposes. Costs associated with entering into derivative financial instruments have not been material to the Company’s consolidated financial results. At September 30, 2025, the notional amount of derivatives not designated as hedging instruments was $3,314 million.
14

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fair Value Hedges
The Company enters into interest rate derivative contracts to manage the exposure to interest rate fluctuations on its funded indebtedness. At September 30, 2025, the Company has interest rate swap agreements, with notional amounts totaling $700 million, $300 million and $300 million, to effectively convert the fixed rate interest on its 2030 Senior Notes, 2031 Senior Notes and 2034 Senior Notes, respectively, to variable interest rates based on the Secured Overnight Financing Rate ("SOFR") plus a margin. These interest rate swap agreements are designated as fair value hedges of the related long-term debt, and the changes in the fair value of the interest rate swap agreements are exactly offset by the change in the fair value of the underlying long-term debt.
The Company enters into cross-currency swap contracts to manage the exposure of foreign exchange rate fluctuations on its intercompany foreign currency denominated debt. At September 30, 2025, the Company has cross-currency swap contracts with notional amounts totaling $491 million, to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt. The cross-currency swap contracts are designated as fair value hedges of the related intercompany debt, and the gains and losses representing hedge components included in the assessment of effectiveness are presented in the same income statement line item as the earnings effect of the hedged transaction in the consolidated statements of earnings (loss). Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized over the life of the hedge on a systematic and rational basis. The earnings recognition of excluded components is presented in the same income statement line item as the earnings effect of the hedged transaction in the consolidated statements of earnings (loss). Any difference between the changes in the fair value of the excluded components and amounts recognized in earnings (loss) will be recognized in Accumulated Other Comprehensive Loss ("AOCI").
The estimated net gain on the Company’s derivative instruments designated as fair value hedges as of September 30, 2025 that is expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months is $14 million. The accumulated net gain on derivative instruments designated as fair value hedges in AOCI was $10 million and $7 million as of September 30, 2025 and June 30, 2025, respectively.
Cash Flow Hedges
The Company enters into foreign currency forward contracts to hedge anticipated transactions and receivables and payables denominated in foreign currencies, for periods consistent with the Company’s identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the cash flows that the Company receives from foreign subsidiaries. The foreign currency forward contracts entered into to hedge anticipated transactions and receivables and payables denominated in foreign currencies have been designated as cash flow hedges and have varying maturities through the end of March 2027. Hedge effectiveness of the foreign currency forward contracts is based on the forward method, which includes forward points in the effectiveness assessment. At September 30, 2025, the Company had cash flow hedges outstanding with a notional amount totaling $1,270 million.
For foreign currency hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued and gains and losses in AOCI are reclassified to Net sales when the underlying forecasted transaction occurs. If it is probable that the forecasted transaction will no longer occur, then any gains or losses in AOCI are reclassified to current-period Net sales. As of September 30, 2025, the Company’s foreign currency cash flow hedges were highly effective.
The Company may enter into interest rate forward contracts to hedge anticipated issuance of debt for periods consistent with the Company’s identified exposures. The purpose of the hedging activities is to minimize the effect of interest rate movements on the cost of debt issuance.
The estimated net loss on the Company’s derivative instruments designated as cash flow hedges as of September 30, 2025 that is expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months is $24 million. The accumulated net gain (loss) on derivative instruments designated as cash flow hedges in AOCI was $3 million and $(13) million as of September 30, 2025 and June 30, 2025, respectively.
15

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Net Investment Hedges
The Company enters into foreign currency forward contracts and cross-currency swap contracts, designated as net investment hedges, to hedge a portion of its net investment in certain foreign operations. Forward points and cross-currency basis spreads, respectively, are excluded from the effectiveness assessment and are recognized under a systematic and rational method over the life of the hedging instrument in Selling, general and administrative expenses. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the Company’s net investment in these foreign operations. The net investment hedge contracts have varying maturities through the end of November 2029. Hedge effectiveness of the net investment hedge contracts is based on the spot method. At September 30, 2025, the Company had net investment hedges outstanding with notional amounts totaling $1,077 million.
Credit Risk
As a matter of policy, the Company enters into derivative contracts only with counterparties that have a long-term credit rating of at least A- or higher by at least two nationally recognized rating agencies. The counterparties to these contracts are major financial institutions. Exposure to credit risk in the event of nonperformance by any of the counterparties is limited to the gross fair value of contracts in asset positions, which totaled $74 million at September 30, 2025. To manage this risk, the Company has strict counterparty credit guidelines that are continually monitored. Accordingly, management believes risk of loss under these hedging contracts is remote.
The fair values of the Company’s derivative financial instruments included in the consolidated balance sheets are presented as follows:

|  | Asset Derivatives |  | Liability Derivatives
|  |  |  | Fair Value (1) |  |  |  | Fair Value (1)
(In millions) |  | Balance Sheet Location |  | September 30, 2025 |  | June 30, 2025 |  | Balance Sheet Location |  | September 30, 2025 |  | June 30, 2025
Derivatives Designated as Hedging Instruments: |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts(2) |  | Prepaid expenses and other current assets; Other assets |  | $ | 6 |  |  | $ | 7 |  |  | Other accrued liabilities |  | $ | 37 |  |  | $ | 82 |
Cross-currency swap contracts(3) |  | Prepaid expenses and other current assets; Other assets |  | 64 |  |  | 50 |  |  | Other accrued liabilities |  | 1 |  |  | 15 |
Interest rate contracts |  | Prepaid expenses and other current assets |  | — |  |  | — |  |  | Other accrued liabilities |  | 100 |  |  | 104 |
Total Derivatives Designated as Hedging Instruments |  |  |  | 70 |  |  | 57 |  |  |  |  | 138 |  |  | 201 |
Derivatives Not Designated as Hedging Instruments: |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | Prepaid expenses and other current assets |  | 4 |  |  | 25 |  |  | Other accrued liabilities |  | 3 |  |  | 15 |
Total derivatives |  |  |  | $ | 74 |  |  | $ | 82 |  |  |  |  | $ | 141 |  |  | $ | 216 |

(1)See Note 5 – Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined.
(2)Included in the asset derivatives for the foreign currency forward contracts at September 30, 2025 is $1 million, classified within Other assets in the accompanying consolidated balance sheets. There were no amounts classified in Other assets at June 30, 2025.
(3)Included in the asset derivatives for the cross-currency swap contracts at September 30, 2025 and June 30, 2025 is approximately $50 million and $40 million, respectively, classified within Other assets in the accompanying consolidated balance sheets.
16

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments that are included in the assessment of effectiveness are as follows:

|  | Amount of Gain (Loss) Recognized in OCI on Derivatives |  | Location of Gain (Loss) Reclassified from AOCI into Earnings |  | Amount of Gain (Loss) Reclassified from AOCI into Earnings (Loss)(1)
|  | Three Months Ended September 30, |  |  | Three Months Ended September 30,
(In millions) |  | 2025 |  | 2024 |  |  | 2025 |  | 2024
Derivatives in Cash Flow Hedging Relationships: |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | 16 |  |  | $ | (47) |  |  | Net sales |  | $ | — |  |  | $ | 10 |
Total cash flow hedges |  | 16 |  |  | (47) |  |  |  |  | — |  |  | 10 |
Derivatives in Net Investment Hedging Relationships(2): |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts(3) |  | — |  |  | (64) |  |  |  |  | — |  |  | — |
Cross-currency swap contracts(4) |  | 15 |  |  | — |  |  |  |  | — |  |  | — |
Total net investment hedges |  | 15 |  |  | (64) |  |  |  |  | — |  |  | — |
Total derivatives |  | $ | 31 |  |  | $ | (111) |  |  |  |  | $ | — |  |  | $ | 10 |

(1)There was no amount reclassified into the accompanying consolidated statements of earnings (loss) as a result of the discontinuance of cash flow hedges because it is probable that forecasted transactions will not occur by the end of the original time period.
(2)Included within translation adjustments as a component of AOCI on the Company’s consolidated balance sheets.
(3)During the three months ended September 30, 2025 and 2024, the gain recognized in the accompanying consolidated statements of earnings (loss) from foreign currency forward contracts related to the amount excluded from effectiveness testing was $3 million and $7 million, respectively.
(4)During the three months ended September 30, 2025, the gain recognized in the accompanying consolidated statements of earnings (loss) from cross-currency swap contracts related to the amount excluded from effectiveness testing was $3 million.

|  |  |  |  |  |  |  | Amount of Gain (Loss) Recognized in Earnings (Loss) on Derivatives |  |  |  |
|  | Location of Gain (Loss) Recognized in Earnings (Loss) on Derivatives |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Three Months Ended September 30, |  |
(In millions) |  |  |  |  |  |  | 2025 |  | 2024 |  |  |  |
Derivatives in Fair Value Hedging Relationships: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cross-currency swap contracts (1) |  | Selling, general and administrative |  |  |  |  |  | $ | 12 |  |  | $ | (53) |  |  |  |  |
Interest rate contracts (2) |  | Interest expense |  |  |  |  |  | $ | 4 |  |  | $ | 41 |  |  |  |  |

(1)Changes in the fair value representing hedge components included in the assessment of effectiveness of the cross-currency swap contracts are exactly offset by the change in the fair value of the underlying intercompany foreign currency denominated debt. The gain recognized in the accompanying consolidated statements of earnings (loss) from cross-currency swap contracts related to the amount excluded from effectiveness testing during the three months ended September 30, 2025 and 2024 was $5 million and $4 million, respectively.
(2)Changes in the fair value of the interest rate contracts are exactly offset by the change in the fair value of the underlying long-term debt.
17

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Additional information regarding the cumulative amount of fair value hedging gain (loss) recognized in the accompanying consolidated statements of earnings (loss) for items designated and qualifying as hedged items in fair value hedges is as follows:

(In millions) |  |  |  |
Line Item in the Consolidated Balance Sheets in Which the Hedged Item is Included |  | Carrying Amount of the Hedged Liabilities |  | Cumulative Amount of Fair Value Hedging Gain (Loss) Included in the Carrying Amount of the Hedged Liability
|  | September 30, 2025 |  | September 30, 2025
Long-term debt |  | $ | 1,185 |  |  | $ | (100) |
Intercompany debt |  | $ | — |  |  | $ | 54 |

Additional information regarding the effects of fair value and cash flow hedging relationships for derivatives designated and qualifying as hedging instruments is as follows:

|  | Three Months Ended September 30,
|  | 2025 |  | 2024
(In millions) |  | Net Sales |  | Selling, General and Administrative |  | Interest Expense |  | Net Sales |  | Selling, General and Administrative |  | Interest Expense
Total amounts of income and expense line items presented in the accompanying consolidated statements of earnings (loss) in which the effects of fair value and cash flow hedges are recorded |  | $ | 3,481 |  |  | $ | 2,296 |  |  | $ | 86 |  |  | $ | 3,361 |  |  | $ | 2,298 |  |  | $ | 92 |
The effects of fair value and cash flow hedging relationships: |  |  |  |  |  |  |  |  |  |  |  |
Gain (loss) on fair value hedge relationships – interest rate contracts: |  |  |  |  |  |  |  |  |  |  |  |
Hedged item |  | N/A |  | N/A |  | (4) |  |  | N/A |  | N/A |  | (41) |
Derivatives designated as hedging instruments |  | N/A |  | N/A |  | 4 |  |  | N/A |  | N/A |  | 41 |
Gain (loss) on fair value hedge relationships – cross-currency swap contracts: |  |  |  |  |  |  |  |  |  |  |  |
Hedged item |  | N/A |  | (12) |  |  | N/A |  | N/A |  | 53 |  |  | N/A
Derivatives designated as hedging instruments |  | N/A |  | 12 |  |  | N/A |  | N/A |  | (53) |  |  | N/A
Gain (loss) on cash flow hedge relationships – foreign currency forward contracts: |  |  |  |  |  |  |  |  |  |  |  |
Amount of gain (loss) reclassified from AOCI |  | — |  |  | N/A |  | N/A |  | 10 |  |  | N/A |  | N/A

N/A (Not applicable)
18

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments are presented as follows:

|  |  |  |  |  |  |  | Amount of Gain (Loss) Recognized in Earnings (Loss) on Derivatives |  |  |  |
|  | Location of Gain (Loss) Recognized in Earnings (Loss) on Derivatives |  |  |  | Three Months Ended September 30, |  |
(In millions) |  |  |  |  |  |  | 2025 |  | 2024 |  |  |  |
Derivatives Not Designated as Hedging Instruments: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | Selling, general and administrative |  |  |  |  |  | $ | 16 |  |  | $ | (50) |  |  |  |  |

The Company's derivative instruments are subject to enforceable master netting agreements. These agreements permit the net settlement of these contracts on a per-institution basis; however, the Company records the fair value on a gross basis on its consolidated balance sheets based on maturity dates, including those subject to master netting arrangements. The following table provides information as if the Company had elected to offset the asset and liability balances of derivative instruments, netted in accordance with various criteria in the event of default or termination as stipulated by the terms of netting arrangements with each of the counterparties:

|  |  | As of September 30, 2025 |  | As of June 30, 2025 |  |
(In millions) |  |  | Gross Amounts of Assets / (Liabilities) Presented in Balance Sheet |  | Contracts Subject to Netting |  | Net Amounts of Assets / (Liabilities) |  | Gross Amounts of Assets / (Liabilities) Presented in Balance Sheet |  | Contracts Subject to Netting |  | Net Amounts of Assets / (Liabilities) |  |  |  |
Derivative Financial Instruments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative assets |  |  | $ | 74 |  |  | $ | (30) |  |  | $ | 44 |  |  | $ | 82 |  |  | $ | (60) |  |  | $ | 22 |  |  |  |  |
Derivative liabilities |  |  | (141) |  |  | 30 |  |  | (111) |  |  | (216) |  |  | 60 |  |  | (156) |  |  |  |  |
Total derivatives |  |  | $ | (67) |  |  | $ | — |  |  | $ | (67) |  |  | $ | (134) |  |  | $ | — |  |  | $ | (134) |  |  |  |  |

NOTE 5 – FAIR VALUE MEASUREMENTS
The Company records certain of its financial assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability, in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. The accounting for fair value measurements must be applied to nonfinancial assets and nonfinancial liabilities that require initial measurement or remeasurement at fair value, which principally consist of assets and liabilities acquired through business combinations and goodwill, indefinite-lived intangible assets and long-lived assets for the purposes of calculating potential impairment. The Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of inputs that may be used to measure fair value are as follows:
Level 1: Inputs based on quoted market prices for identical assets or liabilities in active markets at the measurement date.
Level 2: Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3: Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.
19

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2025:

(In millions) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |  |
Money market funds |  | $ | 448 |  |  | $ | — |  |  | $ | — |  |  | $ | 448 |
Foreign currency forward contracts |  | — |  |  | 10 |  |  | — |  |  | 10 |
Cross-currency swap contracts |  | — |  |  | 64 |  |  | — |  |  | 64 |
Total |  | $ | 448 |  |  | $ | 74 |  |  | $ | — |  |  | $ | 522 |
Liabilities: |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | — |  |  | $ | 40 |  |  | $ | — |  |  | $ | 40 |
Interest rate contracts |  | — |  |  | 100 |  |  | — |  |  | 100 |
Cross-currency swap contracts |  | — |  |  | 1 |  |  | — |  |  | 1 |
Total |  | $ | — |  |  | $ | 141 |  |  | $ | — |  |  | $ | 141 |

The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2025:

(In millions) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets: |  |  |  |  |  |  |  |
Money market funds |  | $ | 727 |  |  | $ | — |  |  | $ | — |  |  | $ | 727 |
Foreign currency forward contracts |  | — |  |  | 32 |  |  | — |  |  | 32 |
Cross-currency swap contracts |  | — |  |  | 50 |  |  | — |  |  | 50 |
Total |  | $ | 727 |  |  | $ | 82 |  |  | $ | — |  |  | $ | 809 |
Liabilities: |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | — |  |  | $ | 97 |  |  | $ | — |  |  | $ | 97 |
Interest rate contracts |  | — |  |  | 104 |  |  | — |  |  | 104 |
Cross-currency swap contracts |  | — |  |  | 15 |  |  | — |  |  | 15 |
Total |  | $ | — |  |  | $ | 216 |  |  | $ | — |  |  | $ | 216 |

The estimated fair values of the Company’s financial instruments not measured at fair value on a recurring basis are as follows:

|  | September 30, 2025 |  | June 30, 2025
(In millions) |  | Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Current and long-term debt |  | $ | 7,323 |  |  | $ | 6,903 |  |  | $ | 7,317 |  |  | $ | 6,794 |
Deferred consideration payable |  | $ | 172 |  |  | $ | 174 |  |  | $ | 322 |  |  | $ | 323 |

20

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following methods and assumptions were used to estimate the fair value of the Company’s financial instruments for which it is practicable to estimate that value:
Cash and cash equivalents – Cash and all highly-liquid securities with original maturities of three months or less are classified as cash and cash equivalents, primarily consisting of cash deposits in interest bearing accounts, time deposits and money market funds (classified within Level 1 of the valuation hierarchy). Cash deposits in interest bearing accounts and time deposits are carried at cost, which approximates fair value, due to the short maturity of cash equivalent instruments.
Foreign currency forward contracts – The fair values of the Company’s foreign currency forward contracts were determined using an industry-standard valuation model, which is based on an income approach. The significant observable inputs to the model, such as swap yield curves and currency spot and forward rates, were obtained from an independent pricing service. To determine the fair value of contracts under the model, the difference between the contract price and the current forward rate was discounted using SOFR forward curves.
Cross-currency swap contracts – The fair values of the Company’s cross-currency swap contracts were determined using an industry-standard valuation model, which is based on the income approach. The significant observable inputs to the model, such as swap yield curves and currency spot and forward rates, were obtained from independent pricing services.
Interest rate contracts – The fair values of the Company’s interest rate contracts were determined using an industry-standard valuation model, which is based on the income approach. The significant observable inputs to the model, such as treasury yield curves, swap yield curves and SOFR forward curves, were obtained from independent pricing services.
Current and long-term debt – The fair value of the Company’s debt was estimated based on the current rates offered to the Company for debt with the same remaining maturities. To a lesser extent, debt also includes finance lease obligations for which the carrying amount approximates the fair value. The Company’s debt is classified within Level 2 of the valuation hierarchy.
Deferred consideration payable – The deferred consideration payable consists primarily of deferred payments associated with the fiscal 2023 fourth quarter acquisition of TOM FORD. The fair value of the payments treated as deferred consideration payable are calculated based on the net present value of cash payments using an estimated borrowing rate based on quoted prices for a similar liability. The Company’s deferred consideration payable is classified within Level 2 of the valuation hierarchy.
NOTE 6 – REVENUE RECOGNITION
Disaggregation of net sales by the Company's geographic regions(1) are as follows:

|  | Three Months Ended September 30,
(In millions) |  | 2025 |  | 2024
The Americas |  | $ | 1,174 |  |  | $ | 1,197 |
Europe, United Kingdom and Ireland and Emerging Markets ("EUKEM") |  | 901 |  |  | 868 |
Asia/Pacific(2) |  | 873 |  |  | 806 |
Mainland China |  | 532 |  |  | 490 |
|  | 3,480 |  |  | 3,361 |
Returns associated with restructuring and other activities |  | 1 |  |  | — |
Net sales |  | $ | 3,481 |  |  | $ | 3,361 |

(1)The Company has reorganized its geographic regions, effective July 1, 2025 and has presented the information for the three months ended September 30, 2025 and 2024 under this new basis.
(2)The net sales from the Company’s travel retail business are included in the Asia/Pacific region.
21

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Accounts Receivable
Accounts receivable, net is stated net of the allowance for doubtful accounts, including credit losses, and customer deductions totaling $39 million and $38 million as of September 30, 2025 and June 30, 2025, respectively. Payment terms are short-term in nature and are generally less than one year.
Changes in the allowance for credit losses are as follows:

(In millions) |  | September 30, 2025
Balance at June 30, 2025 |  | $ | 26 |
Provision for expected credit losses |  | 2 |
Write-offs, net & other |  | (1) |
Balance at September 30, 2025 |  | $ | 27 |

The remaining balance of the allowance for doubtful accounts and customer deductions of $12 million as of September 30, 2025 and June 30, 2025, relates to non-credit losses, which are primarily due to customer deductions.
Deferred Revenue
Changes in deferred revenue are as follows:

|  |  |  | Three Months Ended September 30,
(In millions) |  |  |  |  |  | 2025 |  | 2024
Deferred revenue, beginning of period |  |  |  |  |  | $ | 533 |  |  | $ | 560 |
Revenue recognized that was included in the deferred revenue balance at the beginning of the period |  |  |  |  |  | (127) |  |  | (148) |
Revenue deferred during the period |  |  |  |  |  | 141 |  |  | 154 |
Other |  |  |  |  |  | 1 |  |  | 1 |
Deferred revenue, end of period |  |  |  |  |  | $ | 548 |  |  | $ | 567 |

Transaction Price Allocated to the Remaining Performance Obligations
At September 30, 2025, the combined estimated revenue expected to be recognized in the next twelve months related to performance obligations for customer loyalty programs, gift with purchase promotions, purchase with purchase promotions, gift card liabilities and the Marcolin license arrangement related to TOM FORD that are unsatisfied (or partially unsatisfied) is $332 million. The remaining balance of deferred revenue at September 30, 2025 will be recognized beyond the next twelve months, of which $207 million relates to the non-refundable upfront payment received as part of the Marcolin licensing arrangement that is being recognized on a straight-line basis over the estimated economic life of the license, which is 20 years ending in fiscal 2043.
Royalty Revenue – License Arrangements
The Company’s contractually guaranteed minimum royalty amounts due during future periods under its existing license arrangements is disclosed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
NOTE 7 – PENSION AND POST-RETIREMENT BENEFIT PLANS
The Company maintains pension plans covering substantially all of its full-time employees for its U.S. operations and a majority of its international operations. The Company also maintains post-retirement benefit plans that provide certain medical and dental benefits to eligible employees. Descriptions of these plans are included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
22

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The components of net periodic benefit cost for the three months ended September 30, 2025 and 2024 consisted of the following:

|  | Pension Plans |  | Other than Pension Plans
|  | U.S. |  | International |  | Post-retirement
(In millions) |  | 2025 |  | 2024 |  | 2025 |  | 2024 |  | 2025 |  | 2024
Service cost |  | $ | 9 |  |  | $ | 9 |  |  | $ | 7 |  |  | $ | 7 |  |  | $ | — |  |  | $ | — |
Interest cost |  | 14 |  |  | 13 |  |  | 4 |  |  | 5 |  |  | 2 |  |  | 2 |
Expected return on plan assets |  | (13) |  |  | (13) |  |  | (7) |  |  | (7) |  |  | — |  |  | — |
Amortization of: |  |  |  |  |  |  |  |  |  |  |  |
Actuarial loss (gain) |  | 5 |  |  | 5 |  |  | — |  |  | (1) |  |  | — |  |  | — |
Prior service cost |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | (2) |
Special termination benefits |  | — |  |  | — |  |  | 1 |  |  | — |  |  | — |  |  | — |
Net periodic benefit cost |  | $ | 15 |  |  | $ | 14 |  |  | $ | 5 |  |  | $ | 4 |  |  | $ | 1 |  |  | $ | — |

The amounts recognized in the consolidated balance sheets related to the Company’s pension and post-retirement benefit plans consist of the following:

(In millions) |  | September 30, 2025 |  | June 30, 2025
Other assets |  | $ | 128 |  |  | $ | 128 |
Other accrued liabilities |  | (44) |  |  | (44) |
Other noncurrent liabilities |  | (340) |  |  | (349) |
Funded status |  | (256) |  |  | (265) |
Accumulated other comprehensive loss |  | 264 |  |  | 268 |
Net amount recognized |  | $ | 8 |  |  | $ | 3 |

NOTE 8 – COMMITMENTS AND CONTINGENCIES
Legal Proceedings
The Company is involved, from time to time, in litigation and other legal proceedings incidental to its business, including product liability matters (including asbestos-related claims), advertising, regulatory, employment, intellectual property, real estate, environmental, trade relations, securities, tax, and privacy.
The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely on estimates and assumptions including timing of related payments. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible, and it is able to determine such estimates. Legal defense costs are recognized as incurred when the legal services are provided.
Refer below for the assessment of loss contingencies associated with the Company's Securities Class Action and Derivative Matters and Cosmetic Talcum Powder Matters.
23

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Management believes that the outcome of all remaining current litigation and other legal proceedings will not have a material adverse effect upon the Company’s business, results of operations, financial condition or cash flows. Reasonably possible losses in addition to the amounts accrued for the Company's remaining litigation and legal proceedings are not expected to be material to the Company’s consolidated financial statements. However, management's assessment of the Company's current litigation and other legal proceedings, including the Securities Class Action and Derivative Matters and Cosmetic Talcum Powder Matters, could change in light of the discovery of facts with respect to legal actions or other proceedings pending against the Company not presently known to the Company or determinations by judges, juries or other finders of fact which are not in accord with management's evaluation of the possible liability or outcome of such litigation or proceedings.
Securities Class Action and Derivative Matters
On December 7, 2023 and January 22, 2024, the Company and its then Chief Executive Officer and Chief Financial Officer were named as defendants in separate purported securities class action complaints filed in the United States District Court for the Southern District of New York. On February 20, 2024, those two purported securities class actions were consolidated into one action. On March 22, 2024, plaintiffs filed their consolidated amended class action complaint, which alleges that defendants made materially false and misleading statements during the period February 3, 2022 to October 31, 2023 in press releases, the Company’s public filings and during conference calls with analysts that artificially inflated the price of the Company’s stock in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On March 31, 2025, the Court denied defendants' motion to dismiss. Defendants intend to defend the action vigorously.
On February 1, 2024 and March 15, 2024, stockholder derivative action complaints were filed against certain of the Company’s officers as of those dates, all the Company’s directors as of those dates and certain of the Company’s former directors as of those dates in the United States District Court for the Southern District of New York. In April 2024, both complaints were voluntarily dismissed without prejudice. Subsequently, the Company's Board of Directors ("the Board") received stockholder litigation demands, requesting, among other things, that the Board investigate potential claims on behalf of the Company based on the same alleged course of conduct identified in the securities case complaint (which were also the subject of the voluntarily dismissed stockholder derivative actions complaints) described above. A committee of the Board has been formed to review the stockholder demands and make recommendations, as appropriate in its discretion, to the Board.
In fiscal 2025, on May 8, 2025, two additional stockholder derivative action complaints were filed in the United States District Court for the Southern District of New York against certain of the Company’s current and former officers and directors alleging breach of fiduciary duty and unjust enrichment from the sale of stock by certain individual defendants during the time period surrounding the allegations of false and misleading statements in the purported securities class action described above. Then, on June 23, 2025, another stockholder derivative action complaint was filed in the Supreme Court of the State of New York in Kings County against certain of the Company’s current and former officers and directors, also alleging breach of fiduciary duty and unjust enrichment as well as claims of waste, gross mismanagement and insider trading.
In fiscal 2026, on September 15 and September 26, 2025, two additional stockholder derivative action complaints were filed in Delaware Chancery Court against certain of the Company’s current and former officers and directors, also alleging breach of fiduciary duty and unjust enrichment as well as claims of waste, gross mismanagement and insider trading.
The Company believes that it is not possible at this time to reasonably assess the outcome of these matters or to estimate the loss or range of losses, if any, as the matters are in their early stages.
Cosmetic Talcum Powder Matters
The Company has been named as a defendant in civil actions alleging that certain cosmetic talcum powder products sold by the Company were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries. As of September 30, 2025, there were 91 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 84 cases as of June 30, 2025. During the three months ended September 30, 2025, 15 new cases were filed and 8 cases were resolved by settlement or voluntary dismissal.
24

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In view of the number of cases pending against the Company at June 30, 2024, as well as the evolution of the litigation landscape and expectations regarding future claims at that time, the Company took action from the end of August 2024 through October 2024 to mitigate its future exposure. During that period, the Company reached agreements with certain plaintiff law firms (collectively, the “talcum litigation settlement agreements”) for: (i) the resolution of over 200 pending cosmetic talcum powder matters handled by those firms as well as (ii) a process for resolving potential future cosmetic talcum powder claims expected to be brought on behalf of plaintiffs by those firms from January 1, 2025 through December 31, 2029, with annual capped amounts per year for each participating law firm.
To account for the talcum litigation settlement agreements, the Company recorded a charge of $159 million during the fiscal 2025 first quarter for the amount agreed to settle the current and potential future claims (amounts recorded for potential future claims were based on the best estimate of the probable loss at that time, and actual additional charges and any further reasonably possible losses beyond the amounts recorded during the three months ended September 30, 2024 has not been and is not expected to be material). As of September 30, 2025, $28 million is recorded in Other accrued liabilities and $85 million is recorded in Other noncurrent liabilities in the accompanying consolidated balance sheet related to the talcum litigation settlement agreements.
There are and could be other plaintiff law firms outside of those included in the talcum litigation settlement agreements that bring claims against the Company. The value of other settlements outside of the talcum litigation settlement agreements, either individually or in the aggregate, for the three months ended September 30, 2025 and 2024 was not material. Given the inherent uncertainties of litigation, it is not possible to predict the outcome of all individual cases pending against the Company or potential unasserted claims, and therefore a specific estimate and associated provision is made, as needed, for a small number of individual cases that have advanced to the later stages of legal proceedings. For the remaining filed cases, the Company records an estimate of exposure loss on an aggregated and ongoing basis, which takes into account the historical outcomes of cases the Company has resolved to date. Any adverse outcomes, either in an individual case or in the aggregate, could be material. While the Company and its legal counsel intend to continue to defend these cases vigorously, there can be no assurances regarding the ultimate resolution of these matters. The amounts recorded during the three months ended September 30, 2025 and 2024 for such litigation, outside of the talcum litigation settlement agreements, are not material to the Company's consolidated financial statements. The range of reasonably possible losses in excess of accrued liabilities currently cannot be reasonably estimated for cosmetic talcum matters, outside of the talcum litigation settlement agreements.
The Company believes that a portion of its costs incurred in defending and resolving these claims may be covered by insurance policies issued by several insurance carriers, subject to deductibles, exclusions, retentions and policy limits. Amounts received to date have not been material.
NOTE 9 – STOCK PROGRAMS
Additional information relating to the Company's stock programs are included in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Total net stock-based compensation expense is attributable to the granting of, and the remaining requisite service periods of stock options, restricted stock units (“RSUs”), performance share units (“PSUs”), long-term PSUs, including long-term price-vested units and share units. Compensation expense attributable to net stock-based compensation was $88 million and $74 million for the three months ended September 30, 2025 and 2024, respectively.
Stock Options
During the three months ended September 30, 2025, the Company granted stock options in respect of approximately 1.1 million shares of Class A Common Stock with a weighted average exercise price per share of $91.77 and a weighted average grant date fair value per share of $34.80. The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model.
Restricted Stock Units
During the three months ended September 30, 2025, the Company granted RSUs in respect of approximately 3.5 million shares of Class A Common Stock with a weighted average grant date fair value per share of $91.66 that, at the time of grant, are scheduled to vest at 1.2 million, 1.5 million, and 0.8 million shares per year, in fiscal 2027, fiscal 2028 and fiscal 2029, respectively. Vesting of RSUs is generally subject to the continued employment or the retirement of the grantees. The RSUs are generally accompanied by dividend equivalent rights, payable upon settlement of the RSUs either in cash or shares (based on the terms of the particular award) and, as such, were generally valued at the closing market price of the Company’s Class A Common Stock on the date of grant.
25

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Included in the above are one-time grants in respect of approximately 0.5 million shares of Class A Common Stock scheduled to cliff vest in fiscal 2028 with a weighted average grant-date fair value per share of $91.77 made under the Profit Recovery and Growth Plan Incentive Program which was implemented in an effort to incentivize and retain leaders who are critical to the success of the PRGP.
Performance Share Units
For the PSUs granted in fiscal 2023 with a performance period ended June 30, 2025, the target goals set at the time of issuance were not achieved, resulting in no shares of the Company’s Class A Common Stock issued related to these awards.
Long-term Performance Share Units
On September 2, 2025, the Company issued 68,578 shares of the Company’s Class A Common Stock to its former Chief Executive Officer in accordance with the terms of PSUs granted in March 2021. The total fair value of PSUs at the time of issuance was $6.2 million.
On September 3, 2024, the Company issued 195,940 shares of the Company’s Class A Common Stock to its former Chief Executive Officer in accordance with the terms of PSUs granted in February 2018. The total fair value of PSUs at the time of issuance was $18 million.
Long-term Price-Vested Units
On September 2, 2025, the Company issued 85,927 shares of the Company’s Class A Common Stock to its former Chief Executive Officer in accordance with the terms of price-vested unit awards ("PVUs") granted in March 2021. The total fair value of PVUs at the time of issuance was $7.7 million.
NOTE 10 – NET EARNINGS (LOSS) PER COMMON SHARE
Net earnings (loss) per common share (“basic EPS”) is computed by dividing net earnings (loss) by the weighted average number of common shares outstanding and shares underlying PSUs and RSUs where the vesting conditions have been met. Net earnings (loss) per common share assuming dilution (“diluted EPS”) is computed by reflecting potential dilution from stock-based awards using the treasury stock method. For the three months ended September 30, 2024, the effects of potentially dilutive stock options, PSUs and RSUs were excluded from the computation of diluted EPS as they were anti-dilutive due to the net loss incurred during the period.
26

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
A reconciliation between the numerator and denominator of the basic and diluted EPS computations is as follows:

|  |  |  |  |  | Three Months Ended September 30,
(In millions, except per share data) |  |  |  |  |  |  |  |  |  | 2025 |  | 2024
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net earnings (loss) |  |  |  |  |  |  |  |  |  | $ | 47 |  |  | $ | (156) |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding – Basic |  |  |  |  |  |  |  |  |  | 361.2 |  |  | 359.6 |
Effect of dilutive stock options |  |  |  |  |  |  |  |  |  | — |  | —
Effect of PSUs |  |  |  |  |  |  |  |  |  | — |  | —
Effect of RSUs |  |  |  |  |  |  |  |  |  | 2.1 |  | —
Weighted average common shares outstanding – Diluted |  |  |  |  |  |  |  |  |  | 363.3 |  |  | 359.6 |
Net earnings (loss) per common share: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  |  |  |  |  |  |  |  | $ | .13 |  |  | $ | (.43) |
Diluted |  |  |  |  |  |  |  |  |  | $ | .13 |  |  | $ | (.43) |

The shares of Class A Common Stock underlying stock options, RSUs and PSUs that were excluded in the computation of diluted EPS because their inclusion would be anti-dilutive were as follows:

|  |  |  | Three Months Ended September 30,
(In millions) |  |  |  |  |  | 2025 |  | 2024
Stock options |  |  |  |  |  | 8.5 |  | 7.6
RSUs and PSUs |  |  |  |  |  | 0.7 |  | 1.2

As of September 30, 2025 and 2024, 0.5 million and 0.6 million shares, respectively, of Class A Common Stock underlying PSUs have been excluded from the computation of diluted EPS as the number of shares ultimately issued is contingent on the achievement of applicable performance targets of the Company, as discussed in Note 19 – Stock Programs in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
27

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 11 – EQUITY
Total Stockholders’ Equity

|  |  |  |  |  | Three Months Ended September 30,
(In millions, except per share data) |  |  |  |  |  |  |  |  |  | 2025 |  | 2024
Common stock, beginning of the period |  |  |  |  |  |  |  |  |  | $ | 6 |  |  | $ | 6 |
Stock-based compensation |  |  |  |  |  |  |  |  |  | — |  |  | — |
Common stock, end of the period |  |  |  |  |  |  |  |  |  | 6 |  |  | 6 |
Paid-in capital, beginning of the period |  |  |  |  |  |  |  |  |  | 7,012 |  |  | 6,685 |
Common stock dividends |  |  |  |  |  |  |  |  |  | 3 |  |  | 3 |
Stock-based compensation |  |  |  |  |  |  |  |  |  | 126 |  |  | 90 |
Paid-in capital, end of the period |  |  |  |  |  |  |  |  |  | 7,141 |  |  | 6,778 |
Retained earnings, beginning of the period |  |  |  |  |  |  |  |  |  | 11,672 |  |  | 13,427 |
Common stock dividends |  |  |  |  |  |  |  |  |  | (128) |  |  | (240) |
Net earnings (loss) |  |  |  |  |  |  |  |  |  | 47 |  |  | (156) |
Retained earnings, end of the period |  |  |  |  |  |  |  |  |  | 11,591 |  |  | 13,031 |
Accumulated other comprehensive loss, beginning of the period |  |  |  |  |  |  |  |  |  | (1,127) |  |  | (1,140) |
Other comprehensive (loss) earnings |  |  |  |  |  |  |  |  |  | (14) |  |  | 83 |
Accumulated other comprehensive loss, end of the period |  |  |  |  |  |  |  |  |  | (1,141) |  |  | (1,057) |
Treasury stock, beginning of the period |  |  |  |  |  |  |  |  |  | (13,698) |  |  | (13,664) |
Stock-based compensation |  |  |  |  |  |  |  |  |  | (9) |  |  | (10) |
Treasury stock, end of the period |  |  |  |  |  |  |  |  |  | (13,707) |  |  | (13,674) |
Total equity |  |  |  |  |  |  |  |  |  | $ | 3,890 |  |  | $ | 5,084 |
Cash dividends declared per common share |  |  |  |  |  |  |  |  |  | $ | .35 |  |  | $ | .66 |

28

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of quarterly cash dividends declared per share on the Company’s Class A and Class B Common Stock during the three months ended September 30, 2025:

Date Declared |  | Record Date |  | Payable Date |  | Amount per Share
August 19, 2025 |  | September 2, 2025 |  | September 16, 2025 |  | $ | .35 |

On October 29, 2025, a dividend was declared in the amount of $.35 per share on the Company’s Class A and Class B Common Stock. The dividend is payable in cash on December 15, 2025 to stockholders of record at the close of business on November 28, 2025.
Common Stock
Beginning in December 2022, the Company suspended the repurchase of shares of its Class A Common Stock under its publicly announced program. The Company may resume repurchases in the future.
Accumulated Other Comprehensive Loss
The following table represents changes in accumulated other comprehensive loss, net of tax, by component for the three months ended September 30, 2025:

(In millions) |  | Net Cash Flow Hedge Gain (Loss) |  | Cross-Currency Swap Contracts - Fair Value Hedge Gain(2) |  | Amounts Included in Net Periodic Benefit Cost |  | Translation Adjustments |  | Total
Balance at June 30, 2025 |  | $ | (11) |  |  | $ | 6 |  |  | $ | (204) |  |  | $ | (918) |  |  | $ | (1,127) |
OCI before reclassifications (3) |  | 13 |  |  | 6 |  |  | — |  |  | (32) |  | (1) | (13) |
Amounts reclassified to Net earnings |  | — |  |  | (4) |  |  | 3 |  |  | — |  |  | (1) |
Net current-period OCI |  | 13 |  |  | 2 |  |  | 3 |  |  | (32) |  |  | (14) |
Balance at September 30, 2025 |  | $ | 2 |  |  | $ | 8 |  |  | $ | (201) |  |  | $ | (950) |  |  | $ | (1,141) |

(1)See Note 4 – Derivative Financial Instruments for gains (losses) relating to net investment hedges.
(2)The gain recognized in AOCI, net of tax from cross-currency swap contracts represents the amount excluded from effectiveness testing.
(3)The tax provision included in Net Cash Flow Hedge Gain (Loss), Cross-Currency Swap Contracts - Fair Value Hedge Gain and Translation Adjustments are $3 million, $2 million, and $5 million, respectively.
29

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table represents the effects of reclassification adjustments from AOCI into net earnings (loss) for the three months ended September 30, 2025 and 2024:

|  |  |  |  |  | Amount Reclassified from AOCI |  |  |  |  |  | Affected Line Item in Consolidated Statements of Earnings (Loss)
|  |  |  | Three Months Ended September 30, |  |  |
(In millions) |  |  |  |  |  | 2025 |  | 2024 |  |  |  |  |
Gain (Loss) on Cash Flow Hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  |  |  |  |  | $ | — |  |  | $ | 10 |  |  |  |  |  |  | Net sales
Provision for income taxes |  |  |  |  |  | — |  |  | (3) |  |  |  |  |  |  | Provision (benefit) for income taxes
Total gain on cash flow hedges, net of tax |  |  |  |  |  | — |  |  | 7 |  |  |  |  |  |  | Net earnings (loss)
Gain on Cross-Currency Swap Contracts - Fair Value Hedge |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cross-currency swap contracts |  |  |  |  |  | 5 |  |  | 4 |  |  |  |  |  |  | Selling, general and administrative
Provision for income taxes |  |  |  |  |  | (1) |  |  | (1) |  |  |  |  |  |  | Provision (benefit) for income taxes
Total gain on cross-currency swap contracts - fair value hedge, net of tax |  |  |  |  |  | 4 |  |  | 3 |  |  |  |  |  |  | Net earnings (loss)
Retirement Plan and Other Retiree Benefit Adjustments |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of prior service cost |  |  |  |  |  | 1 |  |  | 2 |  |  |  |  |  |  | Other components of net periodic benefit cost
Amortization of actuarial loss |  |  |  |  |  | (5) |  |  | (4) |  |  |  |  |  |  | Other components of net periodic benefit cost
Total retirement plan and other retiree benefit adjustments, before tax |  |  |  |  |  | (4) |  |  | (2) |  |  |  |  |  |  | Other components of net periodic benefit cost
Benefit for income taxes |  |  |  |  |  | 1 |  |  | — |  |  |  |  |  |  | Provision (benefit) for income taxes
Total retirement plan and other retiree benefit adjustments, net of tax |  |  |  |  |  | (3) |  |  | (2) |  |  |  |  |  |  | Net earnings (loss)
Total reclassification adjustments, net |  |  |  |  |  | $ | 1 |  |  | $ | 8 |  |  |  |  |  |  | Net earnings (loss)

NOTE 12 – STATEMENT OF CASH FLOWS
Supplemental cash flow information for the three months ended September 30, 2025 and 2024 is as follows:

(In millions) |  | 2025 |  | 2024
Cash: |  |  |  |
Cash paid during the period for interest |  | $ | 62 |  |  | $ | 63 |
Cash paid during the period for income taxes |  | $ | 148 |  |  | $ | 195 |
Non-cash investing and financing activities: |  |  |  |
Property, plant and equipment accrued but unpaid |  | $ | 24 |  |  | $ | 26 |
Right-of-use assets obtained in exchange for new/modified operating lease liabilities |  | $ | 53 |  |  | $ | 210 |

30

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 13 – SEGMENT DATA AND RELATED INFORMATION
Operating segments include components of an enterprise for which separate financial information is available that are regularly reviewed by the chief operating decision maker in deciding how to allocate resources and in assessing performance. Although the Company operates in one business segment, beauty products, the chief operating decision maker evaluates performance based on its four major product categories: skin care, makeup, fragrance and hair care. These product categories meet the definition of operating and reportable segments and, accordingly, additional financial data is provided below. Royalty revenue associated with the license of the TOM FORD trademark as well as sales and related results of ancillary products and services that do not fit within the Company's definitions of skin care, makeup, fragrance and hair care are included in the other category.
Segment net sales and operating income is before the impacts of restructuring and other activities and the impacts from the other category described above. Returns and charges associated with restructuring and other activities are not allocated to the Company's segments because they are centrally directed and controlled, are not included in internal measures of segment performance and result from activities that are deemed Company-wide initiatives to redesign, resize and reorganize select areas of the business.
The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information is produced for the chief operating decision maker or included herein.
Information about the Company's four operating segments is as follows:

(In millions) |  | Three Months Ended September 30, 2025
|  | Skin Care |  | Makeup |  | Fragrance |  | Hair Care |  | Total
Net sales |  |  |  |  |  |  |  |  |  | $ | 3,481 |
Less: Other category net sales |  |  |  |  |  |  |  |  |  | 25 |
Less: Returns associated with restructuring and other activities |  |  |  |  |  |  |  |  |  | 1 |
Segment net sales |  | $ | 1,575 |  |  | $ | 1,030 |  |  | $ | 721 |  |  | $ | 129 |  |  | $ | 3,455 |
Cost of sales |  | 419 |  |  | 280 |  |  | 180 |  |  | 36 |  |  | 915 |
Selling, general and administrative expenses |  | 969 |  |  | 765 |  |  | 455 |  |  | 105 |  |  | 2,294 |
Segment operating income (loss) |  | $ | 187 |  |  | $ | (15) |  |  | $ | 86 |  |  | $ | (12) |  |  | $ | 246 |
Other category operating income |  |  |  |  |  |  |  |  |  | 9 |
Charges associated with restructuring and other activities |  |  |  |  |  |  |  |  |  | (86)
Operating income |  |  |  |  |  |  |  |  |  | 169 |
Reconciliation to earnings before income taxes: |  |  |  |  |  |  |  |  |  |
Interest expense |  |  |  |  |  |  |  |  |  | (86)
Interest income and investment income, net |  |  |  |  |  |  |  |  |  | 30 |
Other components of net periodic benefit cost |  |  |  |  |  |  |  |  |  | (4)
Earnings before income taxes |  |  |  |  |  |  |  |  |  | $ | 109 |
Segment depreciation and amortization |  | $ | 90 |  |  | $ | 59 |  |  | $ | 41 |  |  | $ | 8 |  |  | $ | 198 |
Other category |  |  |  |  |  |  |  |  |  | 2 |
Depreciation and amortization |  |  |  |  |  |  |  |  |  | $ | 200 |

31

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(In millions) |  | Three Months Ended September 30, 2024
|  | Skin Care |  | Makeup |  | Fragrance |  | Hair Care |  | Total
Net sales |  |  |  |  |  |  |  |  |  | $ | 3,361 |
Less: Other category net sales |  |  |  |  |  |  |  |  |  | 25 |
Less: Returns associated with restructuring and other activities |  |  |  |  |  |  |  |  |  | —
Segment net sales |  | $ | 1,529 |  |  | $ | 1,038 |  |  | $ | 630 |  |  | $ | 139 |  |  | $ | 3,336 |
Cost of sales |  | 424 |  |  | 295 |  |  | 149 |  |  | 40 |  |  | 908 |
Selling, general and administrative expenses |  | 988 |  |  | 769 |  |  | 421 |  |  | 117 |  |  | 2,295 |
Other segment items(1) |  | — |  |  | 159 |  |  | — |  |  | — |  |  | 159 |
Segment operating income (loss) |  | $ | 117 |  |  | $ | (185) |  |  | $ | 60 |  |  | $ | (18) |  |  | $ | (26) |
Other category operating income |  |  |  |  |  |  |  |  |  | 11 |
Charges associated with restructuring and other activities |  |  |  |  |  |  |  |  |  | (106)
Operating loss |  |  |  |  |  |  |  |  |  | (121)
Reconciliation to loss before income taxes: |  |  |  |  |  |  |  |  |  |
Interest expense |  |  |  |  |  |  |  |  |  | (92)
Interest income and investment income, net |  |  |  |  |  |  |  |  |  | 35 |
Other components of net periodic benefit cost |  |  |  |  |  |  |  |  |  | (2)
Loss before income taxes |  |  |  |  |  |  |  |  |  | $ | (180) |
Segment depreciation and amortization |  | $ | 95 |  |  | $ | 64 |  |  | $ | 39 |  |  | $ | 9 |  |  | $ | 207 |
Other category |  |  |  |  |  |  |  |  |  | 1 |
Depreciation and amortization |  |  |  |  |  |  |  |  |  | $ | 208 |
(1) Other segment items include Talcum litigation settlement agreements

32

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
RESULTS OF OPERATIONS
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. We are a steward of over 20 luxury and prestige brands globally. Our products are sold in approximately 150 countries and territories. We operate as a wholesaler, with our products sold in brick-and-mortar locations and on various e-commerce platforms, including those operated by department stores, duty-free retailers, specialty-multi retailers, online pure players, upscale perfumeries and pharmacies, and top-tier salons and spas. Additionally, we operate a direct-to-consumer business across freestanding stores, our brands' websites and third-party online platforms.

|  |  |  | Three Months Ended September 30, |  |
|  |  |  |  |  | 2025 |  | 2024 |  |  |  |
($ in millions) |  |  |  |  |  | $ |  | % |  | $ |  | % |  |  |  |
Net sales |  |  |  |  |  | $ | 3,481 |  |  | 100.0 | % |  | $ | 3,361 |  |  | 100.0 | % |  |  |  |
Cost of sales |  |  |  |  |  | 927 |  |  | 26.6 |  |  | 928 |  |  | 27.6 |  |  |  |  |
Gross profit |  |  |  |  |  | 2,554 |  |  | 73.4 |  |  | 2,433 |  |  | 72.4 |  |  |  |  |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Selling, general and administrative |  |  |  |  |  | 2,296 |  |  | 66.0 |  |  | 2,298 |  |  | 68.4 |  |  |  |  |
Restructuring and other charges |  |  |  |  |  | 89 |  |  | 2.6 |  |  | 97 |  |  | 2.9 |  |  |  |  |
Talcum litigation settlement agreements |  |  |  |  |  | — |  |  | — |  |  | 159 |  |  | 4.7 |  |  |  |  |
Total operating expenses |  |  |  |  |  | 2,385 |  |  | 68.5 |  |  | 2,554 |  |  | 76.0 |  |  |  |  |
Operating income (loss) |  |  |  |  |  | 169 |  |  | 4.9 |  |  | (121) |  |  | (3.6) |  |  |  |  |
Interest expense |  |  |  |  |  | 86 |  |  | 2.5 |  |  | 92 |  |  | 2.7 |  |  |  |  |
Interest income and investment income, net |  |  |  |  |  | 30 |  |  | 0.9 |  |  | 35 |  |  | 1.0 |  |  |  |  |
Other components of net periodic benefit cost |  |  |  |  |  | 4 |  |  | 0.1 |  |  | 2 |  |  | 0.1 |  |  |  |  |
Earnings (loss) before income taxes |  |  |  |  |  | 109 |  |  | 3.1 |  |  | (180) |  |  | (5.4) |  |  |  |  |
Provision (benefit) for income taxes |  |  |  |  |  | 62 |  |  | 1.8 |  |  | (24) |  |  | (0.7) |  |  |  |  |
Net earnings (loss) |  |  |  |  |  | $ | 47 |  |  | 1.4 | % |  | $ | (156) |  |  | (4.6) | % |  |  |  |

Not adjusted for differences caused by rounding
33

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
The following table is a comparative summary of operating results for the three months ended September 30, 2025 and 2024, for our product categories and geographic regions and reflects the basis of presentation described in Notes to Consolidated Financial Statements, Note 1 – Summary of Significant Accounting Policies and Note 13 – Segment Data and Related Information, for our product categories that meet the definition of reportable segments, for all periods presented. Royalty revenue from license arrangements, and products and services that do not fit within our definitions of skin care, makeup, fragrance and hair care have been included in the “other” category.

|  |  |  | Three Months Ended September 30, |  |
(In millions) |  |  |  |  |  | 2025 |  | 2024 |  |  |  |
NET SALES |  |  |  |  |  |  |  |  |  |  |  |
By Product Category: |  |  |  |  |  |  |  |  |  |  |  |
Skin Care |  |  |  |  |  | $ | 1,575 |  |  | $ | 1,529 |  |  |  |  |
Makeup |  |  |  |  |  | 1,030 |  |  | 1,038 |  |  |  |  |
Fragrance |  |  |  |  |  | 721 |  |  | 630 |  |  |  |  |
Hair Care |  |  |  |  |  | 129 |  |  | 139 |  |  |  |  |
Other |  |  |  |  |  | 25 |  |  | 25 |  |  |  |  |
|  |  |  |  |  | 3,480 |  |  | 3,361 |  |  |  |  |
Returns associated with restructuring and other activities |  |  |  |  |  | 1 |  |  | — |  |  |  |  |
Net sales |  |  |  |  |  | $ | 3,481 |  |  | $ | 3,361 |  |  |  |  |
By Geographic Region(1): |  |  |  |  |  |  |  |  |  |  |  |
The Americas |  |  |  |  |  | $ | 1,174 |  |  | $ | 1,197 |  |  |  |  |
Europe, United Kingdom and Ireland and Emerging Markets ("EUKEM") |  |  |  |  |  | 901 |  |  | 868 |  |  |  |  |
Asia/Pacific |  |  |  |  |  | 873 |  |  | 806 |  |  |  |  |
Mainland China |  |  |  |  |  | 532 |  |  | 490 |  |  |  |  |
|  |  |  |  |  | 3,480 |  |  | 3,361 |  |  |  |  |
Returns associated with restructuring and other activities |  |  |  |  |  | 1 |  |  | — |  |  |  |  |
Net sales |  |  |  |  |  | $ | 3,481 |  |  | $ | 3,361 |  |  |  |  |
OPERATING INCOME (LOSS) |  |  |  |  |  |  |  |  |  |  |  |
By Product Category: |  |  |  |  |  |  |  |  |  |  |  |
Skin Care |  |  |  |  |  | $ | 187 |  |  | $ | 117 |  |  |  |  |
Makeup |  |  |  |  |  | (15) |  |  | (185) |  |  |  |  |
Fragrance |  |  |  |  |  | 86 |  |  | 60 |  |  |  |  |
Hair Care |  |  |  |  |  | (12) |  |  | (18) |  |  |  |  |
Other |  |  |  |  |  | 9 |  |  | 11 |  |  |  |  |
|  |  |  |  |  | 255 |  |  | (15) |  |  |  |  |
Charges associated with restructuring and other activities |  |  |  |  |  | (86) |  |  | (106) |  |  |  |  |
Operating income (loss) |  |  |  |  |  | $ | 169 |  |  | $ | (121) |  |  |  |  |
By Geographic Region(1)(2): |  |  |  |  |  |  |  |  |  |  |  |
The Americas |  |  |  |  |  | $ | 87 |  |  | $ | (85) |  |  |  |  |
EUKEM |  |  |  |  |  | 6 |  |  | 10 |  |  |  |  |
Asia/Pacific |  |  |  |  |  | 150 |  |  | 76 |  |  |  |  |
Mainland China |  |  |  |  |  | 12 |  |  | (16) |  |  |  |  |
|  |  |  |  |  | 255 |  |  | (15) |  |  |  |  |
Charges associated with restructuring and other activities |  |  |  |  |  | (86) |  |  | (106) |  |  |  |  |
Operating income (loss) |  |  |  |  |  | $ | 169 |  |  | $ | (121) |  |  |  |  |

(1) The net sales and operating results from the Company’s travel retail business are included in the Asia/Pacific region.
(2) Operating results by geographic region for the fiscal 2025 first quarter have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 second quarter (quarter-to-date period) furnished amounts, and the adjusted amounts will be reflected in the fiscal 2026 second quarter Form 10-Q. No other periods were impacted and there is no impact on the consolidated financial results or results by product category.
34

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Period-over-period changes in our net sales are generally attributable to the impacts from (i) pricing on our base portfolio, including changes in mix and those due to strategic pricing actions, (ii) volume, including changes driven by the impact of new product innovation, (iii) acquisitions and/or divestitures, and/or (iv) foreign currency translation. The percentages disclosed for these impacts are calculated on an individual basis.
The net sales impact from pricing consists of changes in list prices, due to strategic pricing actions, and mix shifts within and among product categories, geographic regions, brands and distribution channels. The prices at which we sell our products vary by brand, distribution channel (e.g., wholesale or direct-to-consumer) and may also vary by country. Our brands and products cover a broad array of pricing tiers. Prices of skin care and fragrance products are typically higher than makeup and hair care products.
New product innovation includes the introduction of new products, as well as changes related to existing products or where they are sold, including reformulations, regional expansion, repackaging and sets. A product is considered "new innovation" for the twelve-month period following the initial shipment date. Our innovation is launched at different price points than existing products and value derived from innovation may vary from year to year. We continually introduce new products, support new and established products through advertising, merchandising and sampling and phase out existing products that no longer meet the needs of our consumers or our objectives. The economics of developing, producing, launching, supporting and discontinuing products impact our sales and operating performance each period. The introduction of new products often has some cannibalizing effect on sales of existing products, which we take into account in our business planning. The impact of new product introductions, including timing compared to introductions in prior periods, also affects our results.
Non-GAAP Financial Measures
We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business. Management believes that excluding certain items that are not comparable from period to period helps investors and others compare operating performance between periods. While we consider the non-GAAP measures useful in analyzing our results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP. See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
We operate on a global basis, with the majority of our net sales generated outside the United States. Accordingly, fluctuations in foreign currency exchange rates affect our results of operations. Therefore, we present certain net sales, operating results and diluted net earnings (loss) per common share information excluding the effect of foreign currency rate fluctuations to provide a framework for assessing the performance of our underlying business outside the United States. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current-period results using prior-year monthly average foreign currency exchange rates and adjusting for the period-over-period impact of foreign currency cash flow hedging activities.
Outlook
We have experienced challenges within our business and we expect volatility and uncertainty to continue. Although there are signs of stabilization in Mainland China, travel retail conversion continues to be weak and challenges persist in Western Europe, including subdued sentiment. Additionally, within the United States we continue to experience headwinds from challenges in department stores. These challenges are collectively expected to impact net sales and profitability, including impacts to our effective tax rate from changes to our geographical mix of earnings.
We are continuing to monitor and assess the potential effects of new and existing tariffs in the United States as well as in other markets in which we operate. These tariffs have led to significant volatility and uncertainty in global markets and difficulty in forecasting demand. We have implemented and are continuing to implement and consider additional mitigation measures. The impact was not material to fiscal 2026 first quarter profitability and cash flows, however, even if we can minimize some of these impacts, we anticipate higher tariff rates to have an adverse effect on fiscal 2026 profitability and cash flows, and depending on actual rates and countries imposing tariffs such adverse impacts could be material.
35

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
We continue to believe that the best way to increase long-term stockholder value is to provide superior products and services in the most efficient and effective manner while recognizing shifts in consumers’ behaviors and shopping practices. Accordingly, our long-term strategy has numerous initiatives across product categories, brands, geographic regions, channels of distribution and functions designed to grow our sales, provide cost efficiencies, leverage our strengths, such as our history of outstanding creativity and innovation, high quality products and services, and engaging communications, and make us more productive and profitable. With the transition of leadership in the second and third quarters of fiscal 2025, we have embarked on "Beauty Reimagined," a strategic vision which focuses on accelerating best-in-class consumer coverage, creating transformative innovation, boosting consumer-facing investments, fueling sustainable growth through bold efficiencies and reimagining the way we work, including through the expansion of the Profit Recovery and Growth Plan ("PRGP"), as discussed below.
We continue to monitor the effects of the global macro environment, including the risk of recession; currency volatility; inflationary pressures; supply chain challenges; social and political issues; competitive pressures; legal and regulatory matters, including the imposition of tariffs and sanctions; geopolitical tensions; and global security issues. We are also mindful of inflationary pressures (including those caused by tariffs) on our cost base and are monitoring the impact on consumer preferences, the impact of changes being made in the organization, including those related to Beauty Reimagined and the PRGP, as well as the potential impact of changes expected to be made as part of the PRGP on suppliers, retailers and others, and challenges relating to successfully outsourcing select services. In our outlook, we have made assumptions relating to these and other internal and external factors and challenges. Declines in net sales and profitability have, and may continue to, adversely impact the goodwill and other intangible assets associated with our brands, as well as long-lived assets, potentially resulting in impairments.
In December 2021, the Organization for Economic Cooperation and Development issued "Pillar Two" Global Anti-Base Erosion model rules for countries to enact into domestic law that would establish a 15% global minimum tax applied on a country-by-country basis for multinational companies. We are continuing to monitor and evaluate the potential impact of incorporating the global minimum tax in additional countries that have yet to enact the legislation.
On July 4, 2025, new U.S tax legislation was enacted known as the One Big Beautiful Bill Act. This legislation includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of certain business tax provisions. The legislation has multiple effective dates, and we are continuing to evaluate the potential impact of the provisions that are expected to be effective in future fiscal years.
Our ability to recognize deferred tax assets, inclusive of utilizing net operating loss carryforwards, tax credits, and other carryforwards is dependent on the generation of sufficient taxable income in future periods. Accordingly, there can be no assurance that additional valuation allowances on our deferred tax assets will not be required should our financial performance be negatively impacted in the future. Such valuation allowance could be material. We are also monitoring certain provisions in global tax regulations that may expire during fiscal 2026, which, if not extended, could increase our effective tax rate.
Restructuring Program Component of the Profit Recovery and Growth Plan
As announced on November 1, 2023, we launched the PRGP to help progressively rebuild our profit margins in fiscal years 2025 and 2026.
As a component of the PRGP, on February 5, 2024, we announced a two-year restructuring program. We committed to this course of action on February 1, 2024.
After reviewing additional potential initiatives and the progress of previously approved initiatives, on February 3, 2025, we committed to the expansion of the PRGP, including an expansion of the restructuring program.
The expanded component of the restructuring program began during our fiscal 2025 third quarter. The focus of the overall expanded restructuring program (collectively the “Restructuring Program”) includes (i) reorganization and rightsizing of certain areas, (ii) simplification and acceleration of processes, (iii) outsourcing of select services and (iv) evolution of go-to-market footprint and selling models. Specific initiatives under the Restructuring Program are expected to be approved by the end of fiscal 2026 and substantially completed by the end of fiscal 2027.
In connection with the Restructuring Program, as of September 30, 2025 we estimate a net reduction in the range of approximately 5,800 to 7,000 positions globally, which is about 9-11% of our positions including temporary and part-time employees as of June 30, 2023. This net reduction takes into account the elimination of positions after retraining and redeployment of certain employees in select areas.
36

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
We expect that the Restructuring Program will result in restructuring and other charges totaling between $1,200 million and $1,600 million, before taxes, consisting of employee-related costs, asset-related costs, contract terminations and other costs associated with implementing these initiatives, which other than the non-cash charges, are expected to result in future cash expenditures funded from cash provided by operations.
Once fully implemented, we expect the restructuring program to yield annual target gross benefits of between $800 million and $1,000 million, before taxes, a portion of which is expected to be reinvested in consumer-facing activities. The net benefits of the PRGP, which includes the Restructuring Program, are expected to enable a return to a double-digit operating margin over the next few years.
Further information about the Restructuring Program Component of the Profit Recovery and Growth Plan, is described in Notes to Consolidated Financial Statements, Note 3 – Charges Associated with Restructuring and Other Activities herein.
NET SALES

|  |  |  |  |  | Three Months Ended September 30,
($ in millions) |  |  |  |  |  |  |  |  |  | 2025 |  | 2024
As Reported: |  |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  |  |  |  |  |  |  |  | $ | 3,481 |  |  | $ | 3,361 |
$ Change from prior-year period |  |  |  |  |  |  |  |  |  | 120 |  |  |
% Change from prior-year period |  |  |  |  |  |  |  |  |  | 4 | % |  |
Non-GAAP Financial Measure(1): |  |  |  |  |  |  |  |  |  |  |  |
% Change from prior-year period in constant currency |  |  |  |  |  |  |  |  |  | 3 | % |  |

(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Reported net sales increased for the three months ended September 30, 2025, driven by an increase in net sales in the fragrance and skin care product categories.
By geographic region, reported net sales increased across all geographic regions, with the exception of The Americas. The increase in net sales was primarily driven by higher net sales in our travel retail business, and to a lesser extent, in Mainland China.
Reported net sales were impacted by approximately $25 million of favorable foreign currency translation for the three months ended September 30, 2025.
Reported net sales increased 4% for the three months ended September 30, 2025, driven by the increase from pricing of 2% reflecting the favorable impact from strategic price actions and changes in mix, the increase from volume of 1%, and the favorable impact from foreign currency translation of 1%.
Returns associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed a Company-wide initiative to redesign, resize and reorganize select areas of the business. Accordingly, the following discussions of Net sales by Product Categories and Geographic Regions exclude the impacts of return adjustments associated with restructuring and other activities of $1 million for the three months ended September 30, 2025. There were no returns associated with restructuring and other activities for the three months ended September 30, 2024.
37

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Product Categories
Reported net sales for our product categories for the three months ended September 30, 2025 and 2024 were as follows:

|  | Three Months Ended September 30,
($ in millions) |  | 2025 |  | 2024 |  | $ Change |  | % Change |  | % Change in Constant Currency(1) |  |  |  |  |  |
Skin Care |  | $ | 1,575 |  |  | $ | 1,529 |  |  | $ | 46 |  |  | 3 | % |  | 3 | % |  |  |  |  |  |
Makeup |  | 1,030 |  |  | 1,038 |  |  | (8) |  |  | (1) |  |  | (2) |  |  |  |  |  |  |
Fragrance |  | 721 |  |  | 630 |  |  | 91 |  |  | 14 |  |  | 13 |  |  |  |  |  |  |
Hair Care |  | 129 |  |  | 139 |  |  | (10) |  |  | (7) |  |  | (7) |  |  |  |  |  |  |
Other |  | 25 |  |  | 25 |  |  | — |  | — |  |  | — |  |  |  |  |  |  |
|  | 3,480 |  |  | 3,361 |  |  | 119 |  |  | 4 |  |  | 3 |  |  |  |  |  |  |
Returns associated with restructuring and other activities |  | 1 |  |  | — |  | 1 |  |  | 100 |  |  | 100 |  |  |  |  |  |  |
Net sales |  | $ | 3,481 |  |  | $ | 3,361 |  |  | $ | 120 |  |  | 4 | % |  | 3 | % |  |  |  |  |  |

(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
Skin Care
Reported skin care net sales increased $46 million, or 3%, for the three months ended September 30, 2025, reflecting higher net sales from La Mer and Estée Lauder, combined, of approximately $54 million.
Net sales from La Mer increased, primarily driven by higher net sales in our Asia travel retail business, attributable to the low prior-year period net sales base which reflected (i) the challenging retail environment, including low consumer sentiment and conversion from Chinese consumers, as well as (ii) our prior-year efforts to improve in-trade inventory levels. The increase in net sales from Estée Lauder was primarily driven by higher net sales in our Asia travel retail business, as reflected above, and higher net sales in Mainland China, primarily driven by the impacts from new product launches, and reflecting an improvement in the retail environment, including improved consumer sentiment comparatively, to the prior-year period.
Skin care net sales were impacted by approximately $7 million of favorable foreign currency translation for the three months ended September 30, 2025.
Reported skin care net sales increased 3% for the three months ended September 30, 2025, driven by the increase from pricing of 3% reflecting the favorable impact from strategic pricing actions and changes in mix. The impact from volume was flat period-over-period.
Makeup
Reported makeup net sales decreased $8 million, or 1%, for the three months ended September 30, 2025, reflecting lower net sales from Bobbi Brown and Too Faced, combined, of approximately $17 million.
The decrease in net sales from Bobbi Brown was primarily driven by lower net sales in the face subcategory reflecting the unfavorable year-over-year impact of new product launch shipments and lower net sales in the eye subcategory reflecting a reduction in color palettes. Net sales from Too Faced decreased, primarily driven by North America, reflecting lower net sales in the face and eye subcategories.
Partially offsetting the makeup net sales decrease were higher net sales from Estée Lauder, primarily driven by higher net sales in our Asia travel retail business, attributable to the low prior-year period net sales base which reflected (i) the challenging retail environment, including low consumer sentiment and conversion from Chinese consumers, as well as (ii) our prior-year efforts to improve in-trade inventory levels.
38

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Makeup net sales were impacted by approximately $10 million of favorable foreign currency translation for the three months ended September 30, 2025.
Reported makeup net sales decreased 1% for the three months ended September 30, 2025, driven by the decrease from pricing of 1% reflecting changes in mix partially offset by the favorable impact from strategic pricing actions. Partially offsetting the decrease was the favorable impact from foreign currency translation of 1%. The impact from volume was flat period-over-period.
Fragrance
Reported fragrance net sales increased $91 million, or 14% for the three months ended September 30, 2025, primarily driven by higher net sales from Le Labo, TOM FORD, and Jo Malone London, combined, of approximately $76 million. The increase in net sales for Le Labo reflected growth from targeted expanded consumer reach and the success of hero products. Net sales from TOM FORD increased, primarily driven by growth in the Private Blend and Signature franchises, reflecting the benefit from new product launches which created halo benefits on existing products. Net sales from Jo Malone London increased reflecting higher net sales in the cologne subcategory, including success from hero franchises and holiday campaigns, as well as new product launches.
Fragrance net sales were impacted by approximately $8 million of favorable foreign currency translation for the three months ended September 30, 2025.
Reported fragrance net sales increased 14% for the three months ended September 30, 2025, driven by the increase from volume of 8%, an increase from pricing of 5% reflecting changes in mix and the favorable impact from strategic pricing actions, and the favorable impact from foreign currency translation of 1%.
Hair Care
Reported hair care net sales decreased $10 million, or 7%, for the three months ended September 30, 2025, driven by lower net sales from Aveda, reflecting the brand’s strategies to improve long-term performance, including (i) planned reductions in online promotional activity and (ii) the exit from underperforming doors, including freestanding stores. Also contributing to the decrease in Aveda net sales was continued softness in the salon channel. These declines were partially offset by the impact from its launch in Amazon's U.S. Premium Beauty store during the fiscal 2025 fourth quarter.
Reported hair care net sales decreased 7% for the three months ended September 30, 2025, driven by the decrease from volume of 14%, partially offset by an increase from pricing of 6% reflecting changes in mix and the favorable impact from strategic pricing actions.
Geographic Regions
Reported net sales by geographic region for the three months ended September 30, 2025 and 2024 were as follows:

|  | Three Months Ended September 30,
($ in millions) |  | 2025 |  | 2024 |  | $ Change |  | % Change |  | % Change in Constant Currency(2) |  |  |  |  |  |
The Americas |  | $ | 1,174 |  |  | $ | 1,197 |  |  | $ | (23) |  |  | (2) | % |  | (2) | % |  |  |  |  |  |
EUKEM |  | 901 |  |  | 868 |  |  | 33 |  |  | 4 |  |  | — |  |  |  |  |  |  |
Asia/Pacific(1) |  | 873 |  |  | 806 |  |  | 67 |  |  | 8 |  |  | 9 |  |  |  |  |  |  |
Mainland China |  | 532 |  |  | 490 |  |  | 42 |  |  | 9 |  |  | 9 |  |  |  |  |  |  |
|  | 3,480 |  |  | 3,361 |  |  | 119 |  |  | 4 |  |  | 3 |  |  |  |  |  |  |
Returns associated with restructuring and other activities |  | 1 |  |  | — |  |  | 1 |  |  | 100 |  |  | 100 |  |  |  |  |  |  |
Net sales |  | $ | 3,481 |  |  | $ | 3,361 |  |  | $ | 120 |  |  | 4 | % |  | 3 | % |  |  |  |  |  |

(1)The net sales from the Company’s travel retail business are included in the Asia/Pacific region.
(2)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
39

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Reported net sales increased for the three months ended September 30, 2025, primarily driven by higher net sales in Asia/Pacific and in Mainland China, combined, of approximately $109 million.
The increase in net sales in Asia/Pacific was primarily driven by higher net sales in our travel retail business, led by Asia travel retail, attributable to the low prior-year period net sales base which reflected (i) the challenging retail environment, including low consumer sentiment and conversion from Chinese consumers, as well as (ii) our prior-year efforts to improve in-trade inventory levels. Also contributing to the increase in net sales from our travel retail business was higher net sales from our Europe, the Middle East & Africa travel retail business, primarily driven by growth in fragrance.
The increase in net sales in Mainland China for the three months ended September 30, 2025 was primarily driven by the impact from new product launches and the expansion of The Ordinary into the region during the fiscal 2025 third quarter, and also reflected an improvement in the retail environment, including improved consumer sentiment comparatively, to the prior-year period.
Partially offsetting the reported net sales increase was lower net sales in North America, primarily reflecting continued challenges in department stores, including the impact from store closures related to a retailer bankruptcy as well as softness in certain retailers, and elevated levels of inventory for some brands that continued through the quarter. Partially offsetting the net sales decline for North America was growth from shipments in support of our Amazon Premium Beauty stores in the U.S. and Canada, including ongoing brand expansion on the platform.
Reported net sales in The Americas decreased 2% for the three months ended September 30, 2025, driven by the decrease from volume of 3%, partially offset by an increase from pricing of 2% reflecting changes in mix and the favorable impact from strategic pricing actions.
Reported net sales in EUKEM increased 4% for the three months ended September 30, 2025, driven by the favorable impact of foreign currency translation of 4% and an increase from pricing of 3% reflecting the favorable impact from strategic pricing actions and changes in mix. Partially offsetting these increases was the decrease from volume of 3%.
Reported net sales in Asia/Pacific increased 8% for the three months ended September 30, 2025, driven by an increase from pricing of 5% reflecting the favorable impact from strategic pricing actions and changes in mix, and the increase from volume of 4%.
Reported net sales in Mainland China increased 9% for the three months ended September 30, 2025, driven by an increase from volume of 12%, partially offset by a decrease in pricing of 3%, reflecting changes in mix partially offset by the favorable impact from strategic pricing actions.
40

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
GROSS MARGIN
Gross margin increased to 73.4% for the three months ended September 30, 2025, as compared with 72.4% in the prior-year period.

|  |  |  | Favorable (Unfavorable) Basis Points |  |
|  |  |  | September 30, 2025 |  |
|  |  |  | Three Months Ended |  |
As Reported: |  |  |  |  |  |
Mix of business |  |  |  | 50 |  |  |
Obsolescence charges |  |  |  | 20 |  |  |
Manufacturing costs and other |  |  |  | 20 |  |  |
Foreign exchange transactions |  |  |  | (30) |  |  |
Charges associated with restructuring and other activities |  |  |  | 40 |  |  |
As Reported Gross Margin Basis Point Variance |  |  |  | 100 |  |  |
Non-GAAP Financial Measure Adjustments |  |  |  |  |  |
Charges associated with restructuring and other activities |  |  |  | (40) |  |  |
Non-GAAP Gross Margin Basis Point Variance |  |  |  | 60 |  |  |

The increase in gross margin for the three months ended September 30, 2025 reflected net benefits from the PRGP, which included favorable impacts across our mix of business, obsolescence charges and manufacturing costs and other. The favorability within mix of business was driven by reductions in promotional activity, and the favorability within obsolescence charges was driven by reductions in excess inventory. Manufacturing costs and other reflects the favorable impact of cost efficiencies within our global supply chain network, partially offset by the impact of inflation on our costs.
41

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
OPERATING EXPENSES
Operating expenses as a percentage of net sales was 68.5% for the three months ended September 30, 2025, as compared with 76.0% in the prior-year period.

|  |  |  | Favorable (Unfavorable) Basis Points |  |
|  |  |  | September 30, 2025 |  |
|  |  |  | Three Months Ended |  |
As Reported: |  |  |  |  |  |
General and administrative expenses |  |  |  | 90 |  |  |
Advertising, marketing, promotion and product development |  |  |  | 140 |  |  |
Selling |  |  |  | 30 |  |  |
Shipping |  |  |  | 30 |  |  |
Store operating costs |  |  |  | 10 |  |  |
Stock-based compensation |  |  |  | (20) |  |  |
Foreign exchange transactions |  |  |  | (30) |  |  |
Charges associated with restructuring and other activities |  |  |  | 30 |  |  |
Talcum litigation settlement agreements |  |  |  | 470 |  |  |
As Reported Operating Expense Margin Basis Point Variance |  |  |  | 750 |  |  |
Non-GAAP Financial Measure Adjustments: |  |  |  |  |  |
Impact of restructuring and other activities |  |  |  | (40) |  |  |
Talcum litigation settlement agreements |  |  |  | (470) |  |  |
Non-GAAP Operating Expense Margin Basis Point Variance |  |  |  | 240 |  |  |

The favorability in our operating expense margin reflects lower expenses within non-consumer-facing areas of the business, primarily within general and administrative, marketing and product development expenses. These reductions were driven by lower employee-related costs realized through initiatives as part of the PRGP, with the general and administrative favorability partially offset by the year-over-year increase in employee incentive costs. Partially offsetting these expense reductions were increased investments in consumer-facing areas of the business to drive sales, including advertising, selling, promotion and store operating expenses.
42

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
OPERATING RESULTS

|  |  |  | Three Months Ended September 30,
($ in millions) |  |  |  |  |  | 2025 |  | 2024
As Reported: |  |  |  |  |  |  |  |
Operating income (loss) |  |  |  |  |  | $ | 169 |  |  | $ | (121) |
$ Change from prior-year period |  |  |  |  |  | 290 |  |  |
% Change from prior-year period |  |  |  |  |  | 100+% |  |
Operating margin |  |  |  |  |  | 4.9 | % |  | (3.6) | %
Non-GAAP Financial Measure(1): |  |  |  |  |  |  |  |
% Change in operating income (loss) from the prior-year period adjusting for the impact of charges associated with restructuring and other activities and talcum litigation settlement agreements |  |  |  |  |  | 77 | % |  |

(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
The increase in reported operating margin for the three months ended September 30, 2025 was driven by the favorable year-over-year impact of the charge in the fiscal 2025 first quarter associated with the talcum litigation settlement agreements of $159 million, reflected within the favorable operating expense margin, as well as the increase in net sales and increase in gross margin, as discussed above.
Charges associated with restructuring and other activities are not allocated to our product categories or geographic regions because they are centrally directed and controlled, are not included in internal measures of product category or geographic region performance and result from activities that are deemed a Company-wide initiative to redesign, resize and reorganize select areas of the business. Accordingly, the following discussions of Operating income (loss) by Product Categories and Geographic Regions exclude the impact of charges associated with restructuring and other activities for the three months ended September 30, 2025 and 2024 of $86 million and $106 million, respectively.
Product Categories
Reported Operating income (loss) for our product categories for the three months ended September 30, 2025 and 2024 were as follows:

|  | Three Months Ended September 30, |  |  |
($ in millions) |  | 2025 |  | 2024 |  | $ Change |  | % Change (As reported) |  | % Change (Non-GAAP)(1) | Non-GAAP Financial Measure(1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Skin Care |  | $ | 187 |  |  | $ | 117 |  |  | $ | 70 |  |  | 60 | % |  | 60 | % |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Makeup |  | (15) |  |  | (185) |  |  | 170 |  |  | 92 |  |  | 42 |  | Adjusted for the impact of talcum litigation settlement agreements. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fragrance |  | 86 |  |  | 60 |  |  | 26 |  |  | 43 |  |  | 43 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Hair Care |  | (12) |  |  | (18) |  |  | 6 |  |  | 33 |  |  | 33 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other |  | 9 |  |  | 11 |  |  | (2) |  |  | (18) |  |  | (18) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | 255 |  |  | (15) |  |  | 270 |  | 100+ |  | 77 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Charges associated with restructuring and other activities |  | (86) |  |  | (106) |  |  | 20 |  |  | 19 |  |  | 68 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Operating income (loss) |  | $ | 169 |  |  | $ | (121) |  |  | $ | 290 |  |  | 100+% |  | 100+% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

(1)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
43

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Skin Care
Reported skin care operating income increased $70 million, or 60%, for the three months ended September 30, 2025, reflecting an increase in net sales, as well as lower non-consumer-facing expenses, including the reduction in employee-related costs realized through initiatives as part of the PRGP.
Makeup
Reported makeup operating loss decreased $170 million, or 92%, for the three months ended September 30, 2025, primarily reflecting the favorable year-over-year impact of the charge in the fiscal 2025 first quarter associated with the talcum litigation settlement agreements of $159 million, and to a lesser extent lower non-consumer-facing expenses, including the reduction in employee-related costs realized through initiatives as part of the PRGP.
Fragrance
Reported fragrance operating income increased $26 million, or 43%, for the three months ended September 30, 2025, reflecting higher net sales, partially offset by higher cost of sales, and an increase in investments in consumer-facing areas of the business, including selling expenses to support targeted expanded consumer reach, higher promotion expenses to support new product launches, and higher store operating costs to support targeted expanded consumer reach.
Hair Care
Reported hair care operating loss decreased $6 million, or 33%, for the three months ended September 30, 2025, primarily reflecting lower operating expenses and cost of sales, partially offset by lower net sales.
Geographic Regions

|  | Three Months Ended September 30,
($ in millions) |  | 2025 |  | 2024(1) |  | $ Change |  | % Change (As Reported) |  | % Change (Non-GAAP)(2) |  | Non-GAAP Financial Measure(2) |  |  |  |  |  |
The Americas |  | $ | 87 |  |  | $ | (85) |  |  | $ | 172 |  |  | 100+% |  | 18 | % |  | Adjusted for the impact of talcum litigation settlement agreements |  |  |  |  |  |
EUKEM |  | 6 |  |  | 10 |  |  | (4) |  |  | (40) |  | (40) |  |  |  |  |  |  |  |  |
Asia/Pacific(3) |  | 150 |  |  | 76 |  |  | 74 |  |  | 97 |  | 97 |  |  |  |  |  |  |  |  |
Mainland China |  | 12 |  |  | (16) |  |  | 28 |  |  | 100+ |  | 100+ |  |  |  |  |  |  |  |
|  | 255 |  |  | (15) |  |  | 270 |  |  | 100+ |  | 77 |  |  |  |  |  |  |  |  |
Charges associated with restructuring and other activities |  | (86) |  |  | (106) |  |  | 20 |  |  | 19 |  | 68 |  |  |  |  |  |  |  |
Operating income (loss) |  | $ | 169 |  |  | $ | (121) |  |  | $ | 290 |  |  | 100+% |  | 100+% |  |  |  |  |  |  |  |

(1)Operating results by geographic region for the fiscal 2025 first quarter have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 second quarter (quarter-to-date period) furnished amounts, and the adjusted amounts will be reflected in the fiscal 2026 second quarter Form 10-Q. No other periods were impacted and there is no impact on the consolidated financial results or results by product category.
(2)See “Reconciliations of Non-GAAP Financial Measures” beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
(3)The operating results from the Company’s travel retail business are included in the Asia/Pacific region.
Reported operating results in The Americas increased $172 million, or over 100%, for the three months ended September 30, 2025, reflecting the favorable year-over-year impact of the charge in the fiscal 2025 first quarter associated with the talcum litigation settlement agreements of $159 million, and to a lesser extent, lower non-consumer-facing expenses, including the reduction in employee-related costs realized through initiatives as part of the PRGP, and lower cost of sales, partially offset by lower net sales.
44

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Reported operating income in EUKEM decreased $4 million, or 40%, for the three months ended September 30, 2025, reflecting an increase in investments in consumer-facing areas of the business, including to support targeted expanded consumer reach and to support key campaigns and activations, offset by higher net sales.
Reported operating income in Asia/Pacific increased $74 million, or 97%, for the three months ended September 30, 2025, reflecting higher net sales and lower non-consumer-facing expenses, including the reduction in employee-related costs realized through initiatives as part of the PRGP, partially offset by higher cost of sales.
Reported operating results in Mainland China increased $28 million, or over 100%, for the three months ended September 30, 2025, reflecting higher net sales, partially offset by higher cost of sales and the unfavorable year-over-year impact associated with the recognition of local government subsidies in the prior-year period.
INTEREST AND INVESTMENT INCOME

|  |  |  | Three Months Ended September 30,
(In millions) |  |  |  |  |  | 2025 |  | 2024
Interest expense |  |  |  |  |  | $ | 86 |  |  | $ | 92 |
Interest income and investment income, net |  |  |  |  |  | $ | 30 |  |  | $ | 35 |

Interest expense decreased for the three months ended September 30, 2025, primarily reflecting a lower average debt balance compared to the prior-year period. Interest income and investment income, net decreased, primarily reflecting a lower average cash balance and lower average interest rates compared to the prior-year period.
PROVISION FOR INCOME TAXES
The provision or benefit for income taxes represents U.S. federal, foreign, state and local income taxes. The effective rate differs from the federal statutory rate primarily due to the effect of state and local income taxes, the tax impact of stock-based compensation, the taxation of foreign income and income tax reserve adjustments, which represent changes in our net liability for unrecognized tax benefits including tax settlements and lapses of the applicable statutes of limitations, as well as changes to valuation allowances based on our assessment of the realizability of deferred tax assets. Our effective tax rate will change from quarter-to-quarter based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes, tax reserve adjustments, the tax impact of stock-based compensation, changes to valuation allowances, the interaction of various global tax strategies and the impact from certain acquisitions. In addition, changes in judgment from the evaluation of new information resulting in the recognition, derecognition or remeasurement of a tax position taken in a prior annual period are recognized separately in the quarter of change.

|  |  | Three Months Ended September 30,
|  |  |  |  | 2025 |  | 2024
Effective rate for income taxes |  |  |  |  | 56.9 | % |  | 13.3 | %
Basis-point change from the prior-year period |  |  |  |  | 4,360 |  |  |

The increase in the effective tax rate of 4,360 basis points was attributable in part to the loss before income taxes in the fiscal 2025 first quarter as well as the estimated unfavorable impact of the newly enacted U.S. tax legislation, a higher effective tax rate on our foreign operations due to our full year geographical mix of earnings in the current and prior-year periods and an unfavorable impact associated with the establishment of a valuation allowance against current period foreign tax credit and research and development tax credit U.S. deferred tax assets.
45

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
NET EARNINGS (LOSS)

|  |  |  | Three Months Ended September 30,
($ in millions, except per share data) |  |  |  |  |  | 2025 |  | 2024
As Reported: |  |  |  |  |  |  |  |
Net earnings (loss) |  |  |  |  |  | $ | 47 |  |  | $ | (156) |
$ Change from prior-year period |  |  |  |  |  | 203 |  |  |
% Change from prior-year period |  |  |  |  |  | 100+% |  |
Diluted net earnings (loss) per common share |  |  |  |  |  | $ | .13 |  |  | $ | (.43) |
% Change from prior-year period |  |  |  |  |  | 100+% |  |
Non-GAAP Financial Measure(1): |  |  |  |  |  |  |  |
% Change in diluted net earnings (loss) per common share from the prior-year period adjusting for the impact of charges associated with restructuring and other activities and talcum litigation settlement agreements |  |  |  |  |  | 100+% |  |

(1)See “Reconciliations of Non-GAAP Financial Measures” below for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
We use certain non-GAAP financial measures, among other financial measures, to evaluate our operating performance, which represent the manner in which we conduct and view our business. Management believes that excluding certain items that are not comparable from period to period, or do not reflect the Company’s underlying ongoing business, provides transparency for such items and helps investors and others compare and analyze our operating performance from period to period. In the future, we expect to incur charges or adjustments similar in nature to those presented below; however, the impact to the Company’s results in a given period may be highly variable and difficult to predict. Our non-GAAP financial measures may not be comparable to similarly titled measures used by, or determined in a manner consistent with, other companies. While we consider the non-GAAP measures useful in analyzing our results, they are not intended to replace, or act as a substitute for, any presentation included in the consolidated financial statements prepared in conformity with U.S. GAAP. The following tables present Net sales, Operating income (loss) and Diluted net earnings (loss) per common share adjusted to exclude the impact of charges associated with restructuring and other activities; talcum litigation settlement agreements; and the effects of foreign currency translation.
46

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
The following table provides reconciliations between these non-GAAP financial measures and the most directly comparable U.S. GAAP measures.

($ in millions, except per share data) |  | Three Months Ended September 30, |  | Variance |  | % Change |  | % Change in constant currency
| 2025 |  | 2024 |  |  |
Net sales, as reported |  | $ | 3,481 |  |  | $ | 3,361 |  |  | $ | 120 |  |  | 4 | % |  | 3 | %
Returns associated with restructuring and other activities |  | (1) |  |  | — |  |  | (1) |  |  |  |  |
Net sales, as adjusted |  | $ | 3,480 |  |  | $ | 3,361 |  |  | $ | 119 |  |  | 4 | % |  | 3 | %
Operating income (loss), as reported |  | $ | 169 |  |  | $ | (121) |  |  | $ | 290 |  |  | 100+% |  | 100+%
Charges associated with restructuring and other activities |  | 86 |  |  | 106 |  |  | (20) |  |  |  |  |
Talcum litigation settlement agreements |  | — |  |  | 159 |  |  | (159) |  |  |  |  |
Operating income, as adjusted |  | $ | 255 |  |  | $ | 144 |  |  | $ | 111 |  |  | 77 | % |  | 79 | %
Diluted net earnings (loss) per common share, as reported |  | $ | .13 |  |  | $ | (.43) |  |  | $ | .56 |  |  | 100+% |  | 100+%
Charges associated with restructuring and other activities |  | .19 |  |  | .23 |  |  | (.04) |  |  |  |  |
Talcum litigation settlement agreements |  | — |  |  | .34 |  |  | (.34) |  |  |  |  |
Diluted net earnings per common share, as adjusted |  | $ | .32 |  |  | $ | .14 |  |  | $ | .18 |  |  | 100+% |  | 100+%

As diluted net earnings (loss) per common share, as adjusted, is used as a measure of the Company’s performance, we consider the impact of current and deferred income taxes when calculating the per-share impact of each of the reconciling items.
47

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
The following table reconciles the change in net sales by product category and geographic region, as reported, to the change in net sales excluding the effects of foreign currency translation:

|  | As Reported |  | Impact of foreign currency translation |  | Variance, in constant currency |  | % Change, as reported |  | % Change, in constant currency
|  | Three Months Ended September 30, |  |  |  |  |  |
($ in millions) |  | 2025 |  | 2024 |  | Variance |  |  |  |
By Product Category: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Skin Care |  | $ | 1,575 |  |  | $ | 1,529 |  |  | $ | 46 |  |  | $ | (7) |  |  | $ | 39 |  |  | 3 | % |  | 3 | %
Makeup |  | 1,030 |  |  | 1,038 |  |  | (8) |  |  | (10) |  |  | (18) |  |  | (1) |  |  | (2) |
Fragrance |  | 721 |  |  | 630 |  |  | 91 |  |  | (8) |  |  | 83 |  |  | 14 |  |  | 13 |
Hair Care |  | 129 |  |  | 139 |  |  | (10) |  |  | — |  |  | (10) |  |  | (7) |  |  | (7) |
Other |  | 25 |  |  | 25 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
|  | 3,480 |  |  | 3,361 |  |  | 119 |  |  | (25) |  |  | 94 |  |  | 4 |  |  | 3 |
Returns associated with restructuring and other activities |  | 1 |  |  | — |  |  | 1 |  |  | — |  |  | 1 |  |  |  |  |
Total |  | $ | 3,481 |  |  | $ | 3,361 |  |  | $ | 120 |  |  | $ | (25) |  |  | $ | 95 |  |  | 4 | % |  | 3 | %
By Geographic Region: |  |  |  |  |  |  |  |  |  |  |  |  |  |
The Americas |  | $ | 1,174 |  |  | $ | 1,197 |  |  | $ | (23) |  |  | $ | 4 |  |  | $ | (19) |  |  | (2) | % |  | (2) | %
EUKEM |  | 901 |  |  | 868 |  |  | 33 |  |  | (35) |  |  | (2) |  |  | 4 |  |  | — |
Asia/Pacific |  | 873 |  |  | 806 |  |  | 67 |  |  | 4 |  |  | 71 |  |  | 8 |  |  | 9 |
Mainland China |  | 532 |  |  | 490 |  |  | 42 |  |  | 2 |  |  | 44 |  |  | 9 |  |  | 9 |
|  | 3,480 |  |  | 3,361 |  |  | 119 |  |  | (25) |  |  | 94 |  |  | 4 |  |  | 3 |
Returns associated with restructuring and other activities |  | 1 |  |  | — |  |  | 1 |  |  | — |  |  | 1 |  |  |  |  |
Total |  | $ | 3,481 |  |  | $ | 3,361 |  |  | $ | 120 |  |  | $ | (25) |  |  | $ | 95 |  |  | 4 | % |  | 3 | %

48

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
The following table reconciles the change in operating results by product category and geographic region, as reported, to the change in operating results excluding the impact of talcum litigation settlement agreements:

|  | As Reported |  |  |  |  |  | Add: Talcum litigation settlement agreements |  |  |  | Variance, as adjusted |  | % Change, as reported |  | % Change, as adjusted
|  | Three Months Ended September 30, |  |  |  |  |  |  |  |  |
($ in millions) |  | 2025 |  | 2024 |  | Variance |  |  |  |  |  |  |
By Product Category: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Skin Care |  | $ | 187 |  |  | $ | 117 |  |  | $ | 70 |  |  |  |  |  |  | $ | — |  |  |  |  | $ | 70 |  |  | 60 | % |  | 60 | %
Makeup |  | (15) |  |  | (185) |  |  | 170 |  |  |  |  |  |  | (159) |  |  |  |  | 11 |  |  | 92 |  |  | 42 |
Fragrance |  | 86 |  |  | 60 |  |  | 26 |  |  |  |  |  |  | — |  |  |  |  | 26 |  |  | 43 |  |  | 43 |
Hair Care |  | (12) |  |  | (18) |  |  | 6 |  |  |  |  |  |  | — |  |  |  |  | 6 |  |  | 33 |  |  | 33 |
Other |  | 9 |  |  | 11 |  |  | (2) |  |  |  |  |  |  | — |  |  |  |  | (2) |  |  | (18) |  |  | (18) |
|  | 255 |  |  | (15) |  |  | 270 |  |  |  |  |  |  | $ | (159) |  |  |  |  | $ | 111 |  |  | 100+% |  | 77 | %
Charges associated with restructuring and other activities |  | (86) |  |  | (106) |  |  | 20 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total |  | $ | 169 |  |  | $ | (121) |  |  | $ | 290 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
By Geographic Region(1): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
The Americas |  | $ | 87 |  |  | $ | (85) |  |  | $ | 172 |  |  |  |  |  |  | $ | (159) |  |  |  |  | $ | 13 |  |  | 100+% |  | 18 | %
EUKEM |  | 6 |  |  | 10 |  |  | (4) |  |  |  |  |  |  | — |  |  |  |  | (4) |  |  | (40) |  |  | (40) |
Asia/Pacific |  | 150 |  |  | 76 |  |  | 74 |  |  |  |  |  |  | — |  |  |  |  | 74 |  |  | 97 |  |  | 97 |
Mainland China |  | 12 |  |  | (16) |  |  | 28 |  |  |  |  |  |  | — |  |  |  |  | 28 |  |  | 100+ |  | 100+
|  | 255 |  |  | (15) |  |  | 270 |  |  |  |  |  |  | $ | (159) |  |  |  |  | $ | 111 |  |  | 100+% |  | 77 | %
Charges associated with restructuring and other activities |  | (86) |  |  | (106) |  |  | 20 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total |  | $ | 169 |  |  | $ | (121) |  |  | $ | 290 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

(1)Operating results by geographic region for the fiscal 2025 first quarter have been adjusted to reflect the correction of a regional misclassification in the amounts furnished in the Form 8-K on October 2, 2025 related to a one-time charge during the fiscal 2025 first quarter. The misclassification was offset in the fiscal 2025 second quarter (quarter-to-date period) furnished amounts, and the adjusted amounts will be reflected in the fiscal 2026 second quarter Form 10-Q. No other periods were impacted and there is no impact on the consolidated financial results or results by product category.
FINANCIAL CONDITION
LIQUIDITY AND CAPITAL RESOURCES
Overview
Our principal sources of funds historically have been cash flows from operations, borrowings pursuant to our commercial paper program, borrowings from the issuance of long-term debt and committed and uncommitted credit lines provided by banks and other lenders in the United States and abroad. At September 30, 2025, we had cash and cash equivalents of $2,219 million compared with $2,921 million at June 30, 2025. Our cash and cash equivalents are maintained at a number of financial institutions. To mitigate the risk of uninsured balances, we select financial institutions based on their credit ratings and financial strength, and we perform ongoing evaluations of these institutions to limit our concentration risk exposure.
Based on past performance and current expectations, we believe that cash on hand, cash generated from operations, available credit lines and access to credit markets will be adequate to support seasonal working capital needs, currently planned business operations, information technology enhancements, capital expenditures, acquisitions, dividends, stock repurchases, restructuring initiatives, commitments and other contractual obligations on both a near-term and long-term basis.
49

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
The Tax Cuts and Jobs Act resulted in the Transition Tax on unrepatriated earnings of our foreign subsidiaries and changed the tax law in ways that present opportunities to repatriate cash without additional U.S. federal income tax. We continue to analyze the indefinite reinvestment assertion on our remaining applicable foreign earnings. We do not believe that continuing to reinvest these remaining applicable foreign earnings impairs our ability to meet our domestic debt or working capital obligations. If these reinvested earnings were repatriated into the United States as dividends, we would be subject to state income taxes and applicable foreign taxes in certain jurisdictions.
Inflation impacted our operating results in the fiscal 2026 first quarter and we expect it to continue. Generally, we have plans to introduce new products at higher prices, increase prices and implement other operating efficiencies which we expect to offset some of these cost increases.
Credit Ratings
Changes in our credit ratings will likely result in changes in our borrowing costs. Our credit ratings also impact the cost of our revolving credit facilities. Downgrades in our credit ratings may reduce our ability to issue commercial paper and/or long-term debt and would likely increase the relative costs of borrowing. A credit rating is not a recommendation to buy, sell, or hold securities, is subject to revision or withdrawal at any time by the assigning rating organization, and should be evaluated independently of any other rating. As of October 23, 2025, our long-term debt is rated A- with a negative outlook by Standard & Poor’s and A3 with a negative outlook by Moody’s.
50

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Debt
At September 30, 2025, our outstanding borrowings were as follows:

($ in millions) |  | Long-term Debt |  | Current Debt |  | Total Debt
5.150% Senior Notes, due May 15, 2053 ("2053 Senior Notes") (1), (15) |  | $ | 591 |  |  | $ | — |  |  | $ | 591 |
3.125% Senior Notes, due December 1, 2049 (“2049 Senior Notes”) (2), (15) |  | 637 |  |  | — |  |  | 637 |
4.150% Senior Notes, due March 15, 2047 (“2047 Senior Notes”) (3), (15) |  | 495 |  |  | — |  |  | 495 |
4.375% Senior Notes, due June 15, 2045 (“2045 Senior Notes”) (4), (15) |  | 455 |  |  | — |  |  | 455 |
3.700% Senior Notes, due August 15, 2042 (“2042 Senior Notes”) (5), (15) |  | 247 |  |  | — |  |  | 247 |
6.000% Senior Notes, due May 15, 2037 (“2037 Senior Notes”) (6), (15) |  | 295 |  |  | — |  |  | 295 |
5.000% Senior Notes, due February 14, 2034 ("2034 Senior Notes) (7), (15) |  | 640 |  |  | — |  |  | 640 |
5.75% Senior Notes, due October 15, 2033 (“October 2033 Senior Notes”) (8), (15) |  | 198 |  |  | — |  |  | 198 |
4.650% Senior Notes, due May 15, 2033 ("May 2033 Senior Notes") (9), (15) |  | 695 |  |  | — |  |  | 695 |
1.950% Senior Notes, due March 15, 2031 ("2031 Senior Notes") (10), (15) |  | 566 |  |  | — |  |  | 566 |
2.600% Senior Notes, due April 15, 2030 ("2030 Senior Notes") (11), (15) |  | 631 |  |  | — |  |  | 631 |
2.375% Senior Notes, due December 1, 2029 (“2029 Senior Notes”) (12), (15) |  | 645 |  |  | — |  |  | 645 |
4.375% Senior Notes, due May 15, 2028 ("2028 Senior Notes") (13), (15) |  | 698 |  |  | — |  |  | 698 |
3.150% Senior Notes, due March 15, 2027 (“2027 Senior Notes”) (14), (15) |  | 500 |  |  | — |  |  | 500 |
Other long-term borrowings |  | 27 |  |  | — |  |  | 27 |
Other current borrowings |  | — |  |  | 3 |  |  | 3 |
|  | $ | 7,320 |  |  | $ | 3 |  |  | $ | 7,323 |

(1)Consists of $600 million principal, unamortized debt discount of $3 million and debt issuance costs of $6 million.
(2)Consists of $650 million principal, unamortized debt discount of $7 million and debt issuance costs of $6 million.
(3)Consists of $500 million principal, unamortized debt discount of $1 million and debt issuance costs of $4 million.
(4)Consists of $450 million principal, net unamortized debt premium of $9 million and debt issuance costs of $4 million.
(5)Consists of $250 million principal, unamortized debt discount of $1 million and debt issuance costs of $2 million.
(6)Consists of $300 million principal, unamortized debt discount of $3 million and debt issuance costs of $2 million.
(7)Consists of $650 million principal, unamortized debt discount of $2 million, debt issuance costs of $4 million and a $4 million loss to reflect the fair value of interest rate swaps.
(8)Consists of $200 million principal, unamortized debt discount of $1 million and debt issuance costs of $1 million.
(9)Consists of $700 million principal, unamortized debt discount of $1 million and debt issuance costs of $4 million.
(10)Consists of $600 million principal, unamortized debt discount of $2 million, debt issuance costs of $2 million and a $30 million loss to reflect the fair value of interest rate swaps.
(11)Consists of $700 million principal, unamortized debt discount of $1 million, debt issuance costs of $2 million and a $66 million loss to reflect the fair value of interest rate swaps.
(12)Consists of $650 million principal, unamortized debt discount of $3 million and debt issuance costs of $2 million.
(13)Consists of $700 million principal and debt issuance costs of $2 million.
(14)Consists of $500 million principal.
(15)The Senior Notes contain certain customary covenants, including limitations on indebtedness secured by liens.
Total debt as a percent of total capitalization was 65% at September 30, 2025 and June 30, 2025.
Cash Flows

|  | Three Months Ended September 30,
(In millions) |  | 2025 |  | 2024
Net cash flows used for operating activities |  | $ | (340) |  |  | $ | (670) |
Net cash flows used for investing activities |  | $ | (116) |  |  | $ | (160) |
Net cash flows used for financing activities |  | $ | (239) |  |  | $ | (226) |

51

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
The change in net cash flows used for operating activities was primarily driven by higher net earnings in the fiscal 2026 first quarter and a favorable change in operating assets and liabilities variances.
The change in net cash flows used for investing activities was primarily driven by a favorable year-over-year impact from lower capital expenditures compared to the prior-year period.
The change in net cash flows used for financing activities primarily reflected the payment of deferred consideration in the fiscal 2026 first quarter associated with the fiscal 2023 acquisition of TOM FORD, partially offset by a decrease in dividends paid to stockholders in the current-year period.
Dividends
For a summary of quarterly cash dividends declared per share on our Class A and Class B Common Stock during the three months ended September 30, 2025, see Notes to Consolidated Financial Statements, Note 11 – Equity and Redeemable Noncontrolling Interest.
Pension and Post-retirement Plan Funding
There have been no significant changes to our pension and post-retirement funding as discussed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Commitments, Contractual Obligations and Contingencies
There have been no significant changes to our commitments and contractual obligations as discussed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025. For a discussion of contingencies, see Notes to Consolidated Financial Statements, Note 8 – Commitments and Contingencies.
Derivative Financial Instruments and Hedging Activities
For a discussion of our derivative financial instruments and hedging activities, see Notes to Consolidated Financial Statements, Note 4 – Derivative Financial Instruments.
Foreign Exchange Risk Management
For a discussion of foreign exchange risk management, see Notes to Consolidated Financial Statements, Note 4 – Derivative Financial Instruments (Fair Value Hedges, Cash Flow Hedges and Net Investment Hedges).
Credit Risk
For a discussion of credit risk, see Notes to Consolidated Financial Statements, Note 4 – Derivative Financial Instruments (Credit Risk).
Market Risk
We address certain financial exposures through a controlled program of market risk management that includes the use of foreign currency forward contracts to reduce the effects of fluctuating foreign currency exchange rates and to mitigate the change in fair value of specific assets and liabilities on the balance sheet, anticipated transactions and receivables and payables and the net investment in certain foreign operations. To perform a sensitivity analysis of our foreign currency forward contracts, we assess the change in fair values from the impact of hypothetical changes in foreign currency exchange rates. A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our portfolio would have resulted in a net decrease in the fair value of our portfolio of approximately $186 million and $223 million as of September 30, 2025 and June 30, 2025, respectively. This potential change does not consider our underlying foreign currency exposures.
We also enter into cross-currency swap contracts to hedge the impact of foreign currency changes on certain intercompany foreign currency denominated debt and to hedge a portion of the net investment in certain foreign operations. A hypothetical 10% weakening of the U.S. dollar against the foreign exchange rates for the currencies in our cross-currency swap contracts would have resulted in a net decrease in the fair value of our cross-currency swap contracts of approximately $85 million as of September 30, 2025 and June 30, 2025.
In addition, we enter into interest rate derivatives to manage the effects of interest rate movements on our funded indebtedness, including future debt issuances. Based on a hypothetical 100 basis point increase in interest rates, the estimated fair value of our interest rate derivatives would decrease by approximately $63 million and $43 million as of September 30, 2025 and June 30, 2025, respectively.
52

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Our sensitivity analysis represents an estimate of reasonably possible net losses that would be recognized on our portfolio of derivative financial instruments assuming hypothetical movements in future market rates and is not necessarily indicative of actual results, which may or may not occur. It does not represent the maximum possible loss or any expected loss that may occur, since actual future gains and losses will differ from those estimated, based upon actual fluctuations in market rates, operating exposures, and the timing thereof, and changes in our portfolio of derivative financial instruments during the year. We believe, however, that any such loss incurred would be offset by the effects of market rate movements on the respective underlying transactions for which the derivative financial instrument was intended.
OFF-BALANCE SHEET ARRANGEMENTS
We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.
CRITICAL ACCOUNTING POLICIES
As disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025, the discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in conformity with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the amounts of assets, liabilities, revenues and expenses reported in those financial statements. These estimates and assumptions can be subjective and complex, and consequently, actual results could differ from those estimates. Refer to the Critical Accounting Policies and Estimates section within Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025. Since June 30, 2025, there have been no significant changes to the assumptions and estimates related to our critical accounting policies.
RECENTLY ISSUED ACCOUNTING STANDARDS
For a discussion regarding the impact of accounting standards that were recently issued but not yet effective, on our consolidated financial statements, see Notes to Consolidated Financial Statements, Note 1 – Summary of Significant Accounting Policies.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
We and our representatives from time to time make written or oral forward-looking statements, including in this and other filings with the Securities and Exchange Commission, in our press releases and in our reports to stockholders, which may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may address our expectations regarding sales, earnings or other future financial performance and liquidity, other performance measures, product introductions, entry into new geographic regions, information technology initiatives, new methods of sale, our long-term strategy, restructuring and other charges and resulting cost savings, and future operations or operating results. These statements may contain words like “expect,” “will,” “will likely result,” “would,” “believe,” “estimate,” “planned,” “plans,” “intends,” “may,” “should,” “could,” “anticipate,” “estimate,” “project,” “projected,” “forecast,” and “forecasted” or similar expressions. Although we believe that our expectations are based on reasonable assumptions within the bounds of our knowledge of our business and operations, actual results may differ materially from our expectations. Factors that could cause actual results to differ from expectations include, without limitation:
(1)increased competitive activity from companies in the skin care, makeup, fragrance and hair care businesses;
(2)our ability to develop, produce and market new products on which future operating results may depend and to successfully address challenges in our business;
(3)consolidations, restructurings, bankruptcies and reorganizations in the retail industry causing a decrease in the number of stores that sell our products, an increase in the ownership concentration within the retail industry, ownership of retailers by our competitors or ownership of competitors by our customers that are retailers and our inability to collect receivables;
(4)destocking and tighter working capital management by retailers;
53

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
(5)the success, or changes in timing or scope, of new product launches and the success, or changes in timing or scope, of advertising, sampling and merchandising programs;
(6)shifts in the preferences of consumers as to how they perceive value and where and how they shop;
(7)social, political and economic risks to our foreign or domestic manufacturing, distribution and retail operations, including changes in foreign investment and trade policies and regulations of the host countries and of the United States;
(8)changes in the laws, regulations and policies (including the interpretations and enforcement thereof) that affect, or will affect, our business, including those relating to our products or distribution networks, changes in accounting standards, tax laws and regulations, environmental or climate change laws, regulations or accords, trade rules and customs regulations, and the outcome and expense of legal or regulatory proceedings, and any action we may take as a result;
(9)foreign currency fluctuations affecting our results of operations and the value of our foreign assets, the relative prices at which we and our foreign competitors sell products in the same markets and our operating and manufacturing costs outside of the United States;
(10)changes in global or local conditions, including those due to volatility in the global credit and equity markets, government economic policies, natural or man-made disasters, real or perceived epidemics, supply chain challenges, inflation, or increased energy costs, that could affect consumer purchasing, the willingness or ability of consumers to travel and/or purchase our products while traveling, the financial strength of our customers, suppliers or other contract counterparties, our operations, the cost and availability of capital which we may need for new equipment, facilities or acquisitions, the returns that we are able to generate on our pension assets and the resulting impact on funding obligations, the cost and availability of raw materials and the assumptions underlying our critical accounting estimates;
(11)shipment delays, commodity pricing, depletion of inventory and increased production costs resulting from disruptions of operations at any of the facilities that manufacture our products or at our distribution or inventory centers, including disruptions that may be caused by the implementation of information technology initiatives, or by restructurings;
(12)real estate rates and availability, which may affect our ability to increase or maintain the number of retail locations at which we sell our products and the costs associated with our other facilities;
(13)changes in product mix to products which are less profitable;
(14)our ability to acquire, develop or implement new information technology, including operational technology and websites, on a timely basis and within our cost estimates; to maintain continuous operations of our new and existing information technology; and to secure the data and other information that may be stored in such technologies or other systems or media;
(15)our ability to capitalize on opportunities for improved efficiency, such as publicly-announced strategies and restructuring and cost-savings initiatives, and to integrate acquired businesses and realize value therefrom;
(16)consequences attributable to local or international conflicts around the world, as well as from any terrorist action, retaliation and the threat of further action or retaliation;
(17)the timing and impact of acquisitions, investments and divestitures; and
(18)additional factors as described in our filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
We assume no responsibility to update forward-looking statements made herein or otherwise.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
The information required by this item is set forth in Item 2 of this Quarterly Report on Form 10-Q under the caption Liquidity and Capital Resources - Market Risk and is incorporated herein by reference.
54

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Item 4. Controls and Procedures.
Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and to ensure that information required to be disclosed is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. The Chief Executive Officer and the Chief Financial Officer, with assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of September 30, 2025 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.
As part of our review of internal control over financial reporting, we make changes to systems and processes to improve such controls and increase efficiencies, while ensuring that we maintain an effective internal control environment. There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the first quarter of fiscal 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
For a discussion of legal proceedings, see Notes to Consolidated Financial Statements, Note 8 – Commitments and Contingencies.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Share Repurchase Program
We are authorized by the Board of Directors to repurchase shares of our Class A Common Stock in the open market or in privately negotiated transactions, depending on market conditions and other factors. The following table provides information relating to our repurchase of Class A Common Stock during the referenced periods:

Period |  | Total Number of Shares Purchased(1) |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Program |  | Maximum Number of Shares that May Yet Be Purchased Under the Program(2)
July 2025 |  | — |  | $ | — |  |  | — |  | 25,073,242
August 2025 |  | 7,940 |  | 91.38 |  |  | — |  | 25,073,242
September 2025 |  | 91,405 |  | 90.10 |  |  | — |  | 25,073,242
|  | 99,345 |  | 90.20 |  |  | — |  |

(1)Reflects shares that were repurchased by the Company to satisfy tax withholding obligations upon the payout of certain stock-based compensation arrangements.
(2)The Board of Directors has authorized the current repurchase program for up to 256.0 million shares. The total amount was last increased by the Board on October 31, 2018. Our repurchase program does not have an expiration date.
Beginning in December 2022, we suspended the repurchase of shares of our Class A Common Stock under our publicly announced program. We may resume repurchases in the future.
55

Table of Contents
THE ESTÉE LAUDER COMPANIES INC.
Item 5. Other Information.
Trading Arrangements
During the fiscal 2026 first quarter, none of the Company’s directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408(a) of Regulation S-K under the Exchange Act.
Item 6. Exhibits.

Exhibit Number |  | Description
31.1 |  | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (CEO).
31.2 |  | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (CFO).
32.1 |  | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (CEO). (furnished)
32.2 |  | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (CFO). (furnished)
101.1 |  | The following materials from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Earnings (Loss), (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements
104 |  | The cover page from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 is formatted in iXBRL

56

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| THE ESTÉE LAUDER COMPANIES INC.
| By: | /s/ AKHIL SHRIVASTAVA
Date: October 30, 2025 |  | Akhil Shrivastava
|  | Executive Vice President and Chief Financial Officer
|  | (Principal Financial and Accounting Officer)

57